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Abstract
The process of pharmaceutical tablet dissolution is a vital stage in the delivery of
active pharmaceutical ingredients (APIs). The constituent components and their
spatial arrangement within the tablet determine the release characteristics of the
API. It is therefore important to understand and characterise the various processes
and component interactions that occur during tablet dissolution. Computational
simulations of tablet dissolution can be used to obtain parametric sensitivities and
optimise formulations so that the desired API release proﬁle is achieved.
This thesis describes the methods behind modelling the behaviour of non-swelling
and swelling tablets, the mathematical validation of the models, parametric studies
and the experiments which were used to obtain parameters and verify the models.
The experimental method used in this work is Fourier Transform Infrared (FTIR)
spectroscopic imaging, which, when using an attenuated total reﬂection (ATR) ac-
cessory and ﬂow cell, enable chemical and spatial information to be obtained from
the tablet as it dissolves. UV/Visible spectroscopy was also used to obtain drug
release information.
The non-swelling model discretised a tablet over a Cartesian grid and solved the
mass transfer equations (dissolution and diﬀusion) to obtain drug release proﬁles.
Two parametric studies were conducted where the particle size distribution and mass
fractions were varied in one, and the API diﬀusivity, saturated concentration and
mass fraction in the other to see what eﬀect these had on drug release, demonstrating
the importance of the choice of excipient and the impact of particle size on release
variability. For experimental validation, tablets containing diﬀerent quantities of
polyethylene glycol and nicotinamide were dissolved and imaged, and optimisation
was used to obtain the pure component saturated concentrations. The model was
then tested against a diﬀerent tablet to demonstrate the predictive capability of the
model.
The swelling model discretised a tablet into small cylindrical particles, whose
size was proportional to the mass of components within them and whose motion
was determined using the Discrete Element Method (DEM). As water diﬀused into
polymer particles, they could expand, resulting in macroscopic swelling. The DEM
4
5model of a swelling and dissolving tablet was validated against a numerically exact
model of the same tablet and parametric studies were conducted into the eﬀect of
polymer disentanglement threshold, polymer equilibrium water fraction and polymer
dissolution rate. The model was also optimised against a dissolving tablet containing
HPMC to obtain parameters for this excipient.
To conclude, both models were implemented, validated and found to accurately
describe the dissolution kinetics of both swelling and non-swelling tablets.
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1 Introduction
The pharmaceutical industry continues to face challenges in the research and devel-
opment of novel drugs and formulations. Drug development can take up to 16 years
and can cost in excess of $3.1B (Pasquali and Bettini, 2008), whilst the approval
rate of drugs has not changed drastically over the past 30 years (Congress of the
United States Congessional Budget Oﬃce, 2006), putting increasing pressure on the
industry to decrease development time and cost whilst simultaneously ensuring the
safety and eﬃcacy of their products. Although much of the development costs are
drug discovery and clinical trials, the formulation and manufacturing stages remain
a signiﬁcant process in process of bringing a drug to market.
Tablets remain one of the most popular drug delivery methods due to their ease
of manufacturing, physical robustness, consistency of dose and patient compliance.
Unfortunately new drugs tend to be sparingly soluble due to the shift towards larger
and more complex molecules, necessitating increasingly novel ways in which to de-
liver the drug to the target area. This, along with new regulations has prompted
a shift away from Quality by Testing (QbT) to Quality by Design (QbD) on the
reasoning that quality cannot be “tested” into a product, rather it must be designed
in from the start. In the Quality by Testing methodology, the materials used in
tablet manufacture are tested against speciﬁcations (to ensure that the raw ma-
terials function as they should) before being processed to form tablets and batch
tested to ensure the ﬁnal product meets or exceeds speciﬁcations. This leaves much
to be desired as although with the correct inputs and processing parameters the
ﬁnal product should meet speciﬁcations, any change in raw materials (for exam-
ple, a diﬀerent supplier of a bulk excipient) or processing parameters (such as the
installation of new processing equipment or move of production to a diﬀerent ge-
ographical location) can have an unpredictable eﬀect on the quality of the ﬁnal
product leading to its rejection. The root causes of failure are sometimes poorly
understood, resulting in overly strict design speciﬁcations as deviation outside the
design space could lead to unpredictable results (Yu, 2008). Quality by Design is “A
systematic, scientiﬁc, risk-based, holistic and proactive approach to pharmaceutical
development” with “full understanding of how product attributes and process relate
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to product performance” (Nasr, 2006). The QbD approach means that disturbances
can be mitigated along the production line due to intimate understanding of the
eﬀect of critical parameters on the ﬁnal product performance. For example, the
eﬀect of spray drying parameters on the manufacture of insulin particles suggests
that formulation parameters (i.e. upstream) are at least as important as the process-
ing parameters (Maltesen et al., 2008). Exploring the design space using designed
experiments and gaining insight into the eﬀects of parameters on product quality
increase manufacturing ﬂexibility and indicate particularly sensitive parameters.
The move towards QbD means many parameters must be investigated, resulting
in a large number of experiments. Computer modelling oﬀers a way to reduce the
number of experiments, infer parameter values from large data sets and optimise
formulations in-silico. The advantage is that thousands of virtual experiments could
be conducted simultaneously, the only limit being the amount of computing power
available. To realise this requires computer models to be built that can simulate each
stage of tablet manufacture from granulation (Ansari and Štěpánek, 2008) to com-
paction (Sinka et al., 2009) and eventually dissolution and drug release (Maderuelo
et al., 2011).
A model can therefore serve three main functions: To assess the sensitivity of
changing parameters on the performance and variability of the ﬁnal product, to
optimise and increase the robustness of the ﬁnal product and to infer pure component
parameters from data sets that would otherwise be diﬃcult to obtain.
To assess the accuracy and validity of the computer model, it is necessary to do
experiments such as dissolving tablets in dissolution apparatus and comparing the
release of the drug over time to the output from a model (Siepmann and Siepmann,
2008). This approach is limited in that the internal behaviour of the tablet remains
unseen. A novel approach to overcome this limitation is to use ATR-FTIR spectro-
scopic imaging (Kazarian and Chan, 2003), which enables the processes inside the
tablet such as water ingress and swelling to be studied (Kazarian and van der Weerd,
2008). Combining ATR-FTIR spectroscopic imaging with a UV/Visible spectrom-
eter enables simultaneous observation of internal tablet behaviour and overall drug
release (Kazarian et al., 2005).
1.1 Objectives
The main objectives of this work were to model pharmaceutical tablet dissolution
and drug release, compare the model with information from ATR-FTIR spectro-
scopic imaging experiments and investigate various parameters which aﬀect drug
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release or tablet swelling behaviour. Speciﬁcally, the objectives were:
• Construct a 2D non-swelling tablet model and validate it against analytical
solutions. Use this model to investigate the eﬀects of particle location, particle
size distribution and relative component diﬀusivities or saturated concentra-
tions on release rates and release rate variability. Demonstrate the ﬂexibility
of the model and show the sensitivity of each parameter on component release.
• Couple model with optimisation to infer physical property values from experi-
mental data. Obtain experimental data using ATR-FTIR spectroscopic imag-
ing, use it to test the non-swelling model assumptions, and apply UV/Visible
spectroscopy to measure the release curve. Use the model to predict the release
curve of a new (i.e. unknown) tablet.
• Construct a 2D swelling model using the Discrete Element Method (DEM),
develop an algorithm for mass transfer between DEM particles and validate
the mass transfer algorithm against accurate numerical solutions. Compare
the model output with accurate numerical solutions and demonstrate that the
mass transfer algorithm is suﬃciently accurate and fast enough to be used in
this model.
• Investigate the eﬀect of the concentration dependent diﬀusion coeﬃcient, dis-
entanglement threshold and dissolution kinetics on the swelling behaviour of
tablets. Use the results to match the swelling behaviour of an HPMC tablet
(imaged using FTIR spectroscopy) and apply parametric optimisation.
2 Literature review
2.1 Tablet formulation
The most basic pharmaceutical tablet contains two components, the drug or active
phamaceutical ingredient (API) and an excipient which forms a bulk of the tablet.
The excipient’s primary role is to control the release of the drug as it dissolves in
the gastrointestinal tract. Before tablet compaction, the powders must be mixed
and remain stable so that the drug and excipients do not segregate or agglomerate.
The particle sizes must be carefully controlled as with large particle size diﬀerences,
the mixture would separate, with large particles rising to the top above the smaller
particles (Rosato et al., 1987). Particle sizes and ﬂow properties can be controlled
through processes such as milling, dry or wet granulation and sieving.
It is sometimes desirable to impregnate the drug into another medium to en-
hance solubility or maintain the drug’s stability. For example, the amorphous form
of ibuprofen is more kinetically soluble (i.e. it dissolves faster) than the crystalline
form, but the amorphous form is unstable and will revert to the crystalline form over
time. By impregnating ibuprofen into polyethylene glycol (PEG), the amorphous
form is more stable and gives enhanced release (Shakhtshneider et al., 1996). Im-
pregnation can be achieved by melting the drug and excipient together or through
the use of solvents. Unfortunately solvent impregnation can leave traces of the
solvent in the ﬁnal product but can produce a more homogeneous and controlled
distribution of drug in the mixture (Lince et al., 2008; Lee and Lin, 2004). Using
supercritical CO2 is of great interest as it is an eﬀective solvent, safer than many
organic solvents and can be removed simply by depressurisation (Kang et al., 2008;
Li et al., 2008b; Pasquali and Bettini, 2008; Kazarian and Martirosyan, 2002). It
can also be used to remove organic solvents from formulations that may otherwise
be left behind.
There is often more than one excipient in a tablet such as binders, disintegrants,
lubricants, solubility enhancers, taste masking agents, preservatives and colouring
additives. There are often other minor excipients in a tablet. These include binders
which “glue” particles together and control porosity (Štěpánek et al., 2009; Štěpánek,
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Table 2.1: Suggested excipients for tablets or capsules (Wells, 1988).
Excipient Function
Lactose monohydrate (and anhydrous) Excipient
Dicalcium phosphate dihydrate and anhydrous Excipient
Microcrystaline cellulose (Avicel) Excipient
Maize starch (and dried ≤ 5% H2O) Binder and Disintegrant
Modified starch (Starch 1500) Binder and Disintegrant
Polyvinylpyrrolidone (e.g. PVP K30 and 90) Binder
HPMC (3,6 and 15cP) (Methocel/Pharmacoat) Binder
Sodium starch glycollate (Explotab) Disintegrant
Sodium croscarmellose (Ac-Di-Sol) Disintegrant
Magnesium stearate Lubricant
Stearic acid Lubricant
Colloidal silica (Aerosil/Cab-O-Sil) Glidant
2008), lubricants which alter the ﬂow (Faqih et al., 2007) and compaction charac-
teristics (Ellison et al., 2008; He et al., 2007). A list of common excipients can be
seen in Table 2.1. Once the powders or granules are in the correct proportions, they
are fed to a press and compacted to yield the ﬁnal product (Figure 2.1).
The compaction of loose powder into a rigid compact occurs when the particles
undergo rearrangement, elastic (reversible) then plastic deformation (irreversible)
followed by densiﬁcation. The factors aﬀecting powder compaction are the applied
compaction force, the yield stress, the plastic behaviour of the material and the
particle size and arrangement of the material. For Hydroxypropyl Methylcellulose
(HPMC), Gustafsson et al. (2003) noted that the particle shape is particularly im-
portant compared to hydroxypropyl substitution with regards to compaction and
Dabbagh et al. (1996) ﬁnds similarly that larger particles increase the rate of water
ingress due to larger pores. The compaction pressure also aﬀects the ﬁnal tablet
porosity, as higher pressures lead to smaller pores and thus a more dense tablet,
but only up to a certain point (Dabbagh et al., 1996). Bettini et al. (1994) found
that tablets up to 20% porosity did not diﬀer in drug release behaviour due to the
formation of the gel layer. Further compaction can be achieved through the use of
lubricants such as magnesium stearate (Wray et al., 2008; Faqih et al., 2007; Chan
et al., 2005) although too much lubricant can structurally weaken the tablet (He
et al., 2007). For large HPMC particle sizes and high compaction force, a phe-
nomenon termed the “butterﬂy eﬀect” can occur during tablet dissolution, where
the tablet splits axially, resulting in faster drug release (Cahyadi et al., 2011). The
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Figure 2.1: Rotary press production cycle a)top view, b) unfolded view; 1 - die ta-
ble, 2- ﬁll cam, 3-feed wheel with paddles, 4-die ﬁll area, 5-metering
wheel with paddles, 6-pre-compression roller, 7-main compression roller,
8-ejection cam, 9-upper punch, 10-die, 11-lower punch (Sinka et al.,
2009).
reason for this was that tablets compacted axially would have uneven density distri-
butions and thus porosity, resulting in “caps” of high density material with a lower
density center (Busignies et al., 2006) resulting in faster water penetration in the
centre compared to the ends, causing the tablet to split. The use of lubricants can
mitigate against this by spreading the compaction forces more evenly (Ellison et al.,
2008).
As compaction can drastically aﬀect the tablet strength, friability and dissolution
characteristics, modelling compaction is important to understand the internal be-
haviour and optimise the compaction parameters. A common method is the Drucker-
Prager Cap model, improved using the Finite Element Method (FEM) (Sinka et al.,
2004; Cunningham et al., 2004). The ejection of the tablet from the die also cre-
ates large point stresses on the tablet which could lead to structural failure (Han
et al., 2008), hence it is important to take into account all processes within tablet
manufacture from powder mixing and agglomeration to die ﬁlling, compaction and
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ejection.
2.1.1 Cellulose based polymers
A common choice of main excipient are cellulose based polymers such as Hydrox-
ypropyl Methylcellulose (HPMC) (Bolhuis and Armstrong, 2006; Colombo, 1993;
Langer and Peppas, 1983) as they form a gel layer when wet, surrounding the tablet
and controlling the release of drug. These polymers are also biologically inert and
stable over a wide range of pH. Although the polymer of interest in this work is
HPMC, pharmaceutical tablets often use other cellulose based polymers such as mi-
crocrystalline cellulose (MCC), methyl cellulose and ethyl cellulose, which exhibit
diﬀerent swelling and dissolution behaviours. These polymers have a cellulose back-
bone (Figure 2.2) but diﬀer in the hydroxyl group substitutions. Microcrystalline
cellulose does not have any substitutions and thus is very insoluble in water and
does not form a gel layer (O’Connor and Schwartz, 1993), so it is often used as a
binder, ﬁller and/or disintegrant.
Figure 2.2: Cellulose monomer.
In the case of HPMC, the molecular weight of the polymer (i.e. degree of poly-
merisation) and thus viscosity (Mitchell and Balwinski, 2008; Rao et al., 1990) have
an eﬀect on the release rate of drug, especially at low molecular weights. However
with respect to side chain substitution (i.e. hydroxypropyl and methoxy content),
Dahl et al. (1990) found that the hydroxypropyl content had the greatest inﬂuence
on drug release compared to the methoxyl content. A more recent study of the same
molecular weight HPMC with diﬀerent methoxyl substitutions conﬁrmed that this
had little eﬀect on the swelling kinetics and water ingress (Escudero et al., 2010).
Diﬀerent degrees of hydroxypropyl and methoxyl substitution do inﬂuence the or-
ganic solubility and thermal gelation temperature, which is important during tablet
manufacture (drug impregnation) while diﬀerent viscosity grades inﬂuence the for-
mation of the gel layer and the release rate of drug (The Dow Chemical Company,
2000). A review of factors concerning drug release shows that there are many factors
that inﬂuence the release of drug, the type of polymer (not just HPMC) and the
viscosity of the gel layer being the main ones (Maderuelo et al., 2011).
2.2. TABLET DISSOLUTION 31
Basket
Tablet
(a)
Paddle
Tablet
(b)
Figure 2.3: USP dissolution apparatus showing the basket (USP1) (a) and paddle
(USP2) (b) methods.
2.2 Tablet dissolution
2.2.1 Analytical methods
The desired dissolution proﬁle of tablets is determined by the type of drug and how it
should be released. A dissolution or release proﬁle is a graph of the quantity of drug
released from a tablet over time. This is usually measured from the bulk solution the
drug dissolves into, which can be either water or simulated gastric ﬂuid. Ultimately,
the compaction of the powder mixture, the spatial arrangement of components and
the components themselves determine the release rate of drug. Dissolution is usually
tested using United States Pharmacopeia dissolution apparatus (USP, 2007; FDA,
2006), the most common being USP1 and USP2 as shown in Figure 2.3. Samples of
the bulk solution are removed from the dissolution vessels and analysed by UV spec-
troscopy to produce the drug release proﬁle. The dissolution apparatus is controlled
so that the temperature of the vessel, rotation speed of the paddle or basket and
the bulk solution chemistry are within approved limits, however there can still be
wide variability in the release (Qureshi and Shabnam, 2001) due to small variations
in the apparatus. Other USP certiﬁed methods for evaluating drug release are USP
3, reciprocating cylinder (Melia and Davis, 1989b), and USP4, a ﬂow-through cell
(Singh and Aboul-Enein, 2006).
The USP methods are unable to show the processes occurring inside the tablet,
merely to show the result of those processes. It is possible to use methods such as
magnetic resonance imaging (MRI) (Kaunisto et al., 2010; Nott, 2010; Fyfe et al.,
2000) or changes in refractive index (Gao and Meury, 1996; Pham and Lee, 1994)
to see what happens as the tablet swells and dissolves (for tablets that use swelling
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excipients). A method of visualising water ingress and importantly, drug diﬀusion
can be achieved by adding the drug Buﬂomedil, which changes colour when wet
from yellow/white to a rich orange (Colombo et al., 2000, 1999b,a, 1996; Bettini
et al., 1994). However Kazarian and van der Weerd (2008) noted that the reported
position or existence of fronts (i.e. positions of water ingress, polymer swelling,
drug dissolution) based on colour or refractive index changes was inconsistent and
did not reﬂect the true location of fronts within the tablet. Fourier transform in-
frared (FTIR) spectroscopic imaging (Section 2.5) provides more insight into tablet
dissolution and is used in this work.
2.2.2 Polymer dissolution
The release of drugs is determined mainly by the behaviour of the polymer ma-
trix and polymers undergoing dissolution tend to go through two main processes,
one is gel formation and the other is polymer dissolution (chain disentanglement).
Unlike materials which dissolve quickly (where quickly in this case refers to the
transfer of material from solid to liquid phase directly, without the formation of
any meso-phases), polymeric materials have two states when in the solid phase and
dissolve more slowly. These states are the glassy or rubbery states, and the state
of the polymer depends on the glass transition temperature Tg. When the poly-
mer’s temperature is below Tg, it is in the glassy state (which can be crystalline
or amorphous) and the polymer chains do not have the energy to move freely and
overcome the intermolecular forces between the chains. If an uncrosslinked polymer
is heated to above Tg, the polymer enters the rubbery or gel phase, where the chains
are more mobile and the tensile strength of the material decreases. Further heating
causes the chains to become very mobile and the polymer becomes a viscous liquid.
In pharmaceutical polymer dissolution, the transition between glassy and rubbery
phases does not occur by heating but instead due to plasticisation, where solvent
molecules diﬀuse between the polymer chains, enabling them to move freely and in
eﬀect, lowering the glass transition temperature. The polymer chains relax and take
up more volume due to the presence of solvent and swelling occurs.
The rubbery polymer is frequently referred to as the “gel layer” (Gazzaniga et al.,
2008; Miller-Chou and Koenig, 2003; Harland et al., 1988; Lee and Peppas, 1987). At
the interface between the rubbery polymer and solvent, chain disentanglement occurs
where polymer chains diﬀuse into the solvent. The process of polymer dissolution
can be seen as water penetration into the glassy phase, polymer transition from
glassy to rubbery phase and polymer chain disentanglement into the bulk solution,
an example of which can be seen in Figure 2.4.
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Figure 2.4: Stages of polymer dissolution as shown by Siepmann et al. (1999a).
Tablets may undergo physical disintegration (Melia and Davis, 1989b) in cases
where the drug release needs to be fast (Goddeeris et al., 2008), hence the use of
disintegrants in these formulations.
2.2.3 Drug release
The ideal release proﬁle for a chronically administered drug (e.g. for tablets which
are taken daily) is linear, releasing at a constant rate until the tablet has dissolved
completely. This is known as “zero order” release (Andjelić et al., 2006; Nujoma
and Kim, 1996) and can be achieved using swelling polymers in a sandwich conﬁg-
uration, where the swelling polymer and drug are surrounded by insoluble barriers
(Maggi et al., 2000; Varelas et al., 1995; Conte et al., 1993). Modulated release
using multicore or biphasic tablet designs is also possible (Gazzaniga et al., 2008; Li
et al., 2008a; Kikkinides et al., 1998; Maggi et al., 1993). All of these methods use
spatial arrangement of the drug and excipients to achieve zero order release, but an
alternative method uses smart polymers, which release the drug based on the local
environment (Qiu and Park, 2001). This is better than zero order release, as the
drug is released as and when it’s needed (Chaterji et al., 2007). For the time being,
swelling polymers remain a popular method for controlling drug release thus they
are the focus of this work.
During swelling polymer tablet dissolution, drug particles within the tablet dis-
solve and diﬀuse through the gel layer, the primary method in which release is
controlled. As the gel layer expands, drug particles are pushed towards the poly-
mer dissolution front, resulting in drug particle translocation (Kazarian and van der
Weerd, 2008; Bettini et al., 2001; Adler et al., 1999). Sometimes there is a short
burst of drug release due to drug particles being on the outer edge of the tablet and
there being a small delay whilst the polymer hydrates and forms a gel (Dabbagh
et al., 1996). The polymer can have interactions with the drug itself, for example
ibuprofen can dissolve in polyethylene glycol (PEG) solutions more readily than it
does in pure water. If the PEG dissolves too quickly, the ibuprofen can crystallise
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out (Kazarian and Chan, 2003), irritating the lining of the stomach (Lanza et al.,
1979). Drugs that are sensitive to low pH environments would need to be protected
while in the stomach and this can be achieved by using enteric coatings such as EU-
DRAGIT (a methacrylic acid copolymer) (Liu et al., 2009) or Hypromellose acetate
succinate (HPMCAS) (Tanno et al., 2008).
2.3 Tablet dissolution modelling
Modelling tablet dissolution is an important component in the Quality by Design
(QbD) approach for the manufacture of oral dosage forms (Yu, 2008). QbD inves-
tigates factors that aﬀect the quality and characteristics of the end product with
the aim of being able to mitigate disturbances before they reach the end product
through understanding of the design space and its associated parameters (Troyankin
et al., 2009). In order to explore the design space and quantify the eﬀect of changing
parameters, modelling is required. The methods of modelling can be divided into
two categories; “ground-up”, where the physical properties of the pure components,
their spatial arrangement and fundamental mass transfer equations are known and
thus can simulate a tablet dissolving and “top-down”, where drug release curves are
modelled using statistical analysis. The latter case can use statistical modelling
packages such ANOVATM to ﬁnd correlations between input parameters and the re-
sulting release curves (Escudero et al., 2008), or use neural networks which must be
trained with suﬃcient experimental data (Chansanroj et al., 2011; Peh et al., 2000).
These models are only as good as the data they are given and the relationships
between inputs and outputs are obfuscated. Methods using the ground-up approach
but with statistical models used to account for mass transfer such as Monte-Carlo
and cellular automata methods can also be used (Laaksonen et al., 2009; Barat et al.,
2006). Many diﬀerent models exist, each with their own merits (such as swelling
in 3D (Borgquist et al., 2006) and robust thermodynamic derivation of polymer
behaviour (Narasimhan and Peppas, 1996)) and drawbacks (such as assumptions
about the homogeneous nature of the system or geometric restrictions) (Siepmann
and Siepmann, 2008; Dokoumetzidis and Macheras, 2006; Miller-Chou and Koenig,
2003; Costa and Sousa Lobo, 2001; Narasimhan, 2001) but apart from the curve
ﬁtting models (such as the Weibull model), most can be traced back to fundamental
principles of mass transfer (Fick’s law).
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2.3.1 Zero and first-order equations
The most basic model of dissolution can be considered in the same way as that of a
zero-order reaction where mt is the mass of drug released at time t, m0 is the initial
mass and kdiss is a dissolution constant (Eq. 2.1).
mt = m0 − kdisst (2.1)
This model is entirely linear and produces a desirable release proﬁle as the rate of
release is constant throughout.
First-order dissolution can be seen in its most common form as the Noyes-Whitney
equation (Dokoumetzidis and Macheras, 2006; Melia and Davis, 1989a) which de-
scribes the change in concentration in the solution over time:
dc
dt
= K(csat − cbulk ) (2.2)
Equation 2.2 can be written with respect to the surface area available for dissolu-
tion and is a condensed form Fick’s ﬁrst law with ﬁxed boundary conditions and
diﬀusion length, where the area A, diﬀusion coeﬃcient D and diﬀusion length ∆x
are condensed into the constant K:
V
dc
dt
=
DA
∆x
(csat − cbulk) (2.3)
2.3.2 Higuchi model
The Higuchi model describes dissolution from a homogeneous matrix in a planar
system (Figure 2.5) where ft is the mass fraction of drug released at time t, c0 is the
initial drug concentration and csat is the drug saturated concentration in the matrix
media:
ft =
√
D(2c− csat)csat t (2.4)
The derivation of this equation is described in Costa and Sousa Lobo (2001) and
is based on Figure 2.5 where the amount of drug released is represented by the
grey area, and the dotted lines show where the grey area would be after another
small time step, thus obtaining Equation 2.4 when this is integrated over time. The
Higuchi model can be simpliﬁed into the following form where KH is the Higuchi
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Direction of drug release
c
sat
c
Distance
Solution
(perfect sink)
Release surface
Δx
x=0
Figure 2.5: Drug theoretical concentration proﬁle of a matrix system in direct con-
tact with a perfect sink release media (adapted/redrawn from Costa and
Sousa Lobo (2001)).
constant:
ft = KHt
1
2 (2.5)
This model is only valid if the porous matrix does not undergo signiﬁcant alteration
in the presence of water, for example, if the matrix was a pre-swollen crosslinked
hydrogel (or a hydrogel which expanded to reach equilibrium much faster than drug
would be released from it). However, this is not the case for most swelling polymers,
which undergo signiﬁcant changes over time as already discussed in Section 2.2.2.
2.3.3 Peppas model
The concept of release being proportional to the square root of time is found exten-
sively in solutions to Fick’s law (Crank, 1975) and is also the basis for the Korsmeyer-
Peppas model in which the mass fraction of drug released is related to an exponent
of the time elapsed. It is based on a truncated solution of Fick’s second law for
diﬀusion of solute from a thin polymer slab of thickness l:
ft = 4
[
Dt
l2
] 1
2
[
1
π1/2
+ 2
∞∑
n=1
(−1)nierfc nl
2
√
Dt
]
(2.6)
(2.7)
For small times (i.e. ft ≤ 0.60), Equation 2.7 can be reduced to:
ft = 4
[
Dt
l2
] 1
2
(2.8)
The general form can be rewritten as Equation 2.9 (Ritger and Peppas, 1987a).
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ft = kt
m (2.9)
Ritger and Peppas (1987a) found that for slabs m = 0.5, but adjustment of this
exponent means the general form matches with other analytical solutions for cylin-
ders (m = 0.451± 0.004) and spheres (m = 0.432± 0.007). The special case where
m = 1 indicates drug release is independent of geometry and is zero order.
An improvement to the Peppas model takes into account swelling or Case-II trans-
port. For a polymer ﬁlm undergoing swelling with cross sectional area A and a
swollen region deﬁned as X ≤ x ≤ l
2
where X is the position of the advancing front,
the rate of release is assumed to be controlled by a ﬁrst order expression (Equation
2.10) with a relaxation constant k0. In the glassy region (0 ≤ x ≤ X) there is no
drug diﬀusion (Ritger and Peppas, 1987b).
dmt
dt
= k0A (2.10)
The mass released from this swollen region is also given as:
mt = c0V = c0A
[
l
2
−X
]
(2.11)
Integrating Equation 2.10 and using Equation 2.11, the fractional release from this
region can be given:
mt
m∞
=
2k0
c0l
t (2.12)
The expression (Eq. 2.12) can be simpliﬁed and combined with Equation 2.9 to give
the fraction of drug released as a summation of the contribution from diﬀusion and
relaxation (Ritger and Peppas, 1987b) to give:
ft = k1t
m + k2t
2m (2.13)
The value of m in Equation 2.13 is 0.5 for release from plane sheets, and has other
values depending on geometry and release mechanism (Table 2.2).
The Peppas model can also be rewritten in terms of a ratio between the relax-
ational and Fickian contributions over the course of drug release:
Relaxational
Fickian
=
k2
k1
tm (2.14)
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Table 2.2: Diﬀusional exponent m for equation 2.13 and mechanism of release from
various swellable controlled release systems (Reproduced from (Ritger
and Peppas, 1987b)).
Diffusional exponent, m
Drug release mechanism
Thin film Cylindrical sample Spherical sample
0.5 0.45 0.43 Fickian diffusion
0.5<m<1.0 0.45<m<0.89 0.43<m<0.85 Anomalous (non Fickian) Transport
1.0 0.89 0.85 Case-II transport
Although this model is only valid for drug release fractions up to 60%, it has been
used extensively to characterise release from tablets. Chan (2004) found that low
molecular weight cast PEG ﬁlms release their drugs in a Fickian manner, but as
molecular weight increases, there is greater contribution from the Case-II transport.
Similarly, Miranda et al. (2006) used the Peppas model to analyse the mode of re-
lease for HPMC tablets containing KCl of diﬀering weight fractions. It was reported
that between 20% w/w and 70% w/w of drug, the release kinetics were Fickian and
above this, erosion was the primary mechanism (non-Fickian) due to the percola-
tion threshold. The Peppas model assumes constant diﬀusivity within the polymer
matrix, which for HPMC and other swelling matrices is generally untrue. Rekhi
et al. (1999) and Colombo et al. (1999a) found a wide range of exponents when
ﬁtting data to the ﬁrst form of the Peppas model (Equation 2.9), indicating anoma-
lous release. The second form (Equation 2.13) has been used to study the eﬀect
of molecular weight of HPMC (METHOCELTM K4M, K15M and K100M) on drug
release from cylindrical tablets where in some cases, coatings were applied to the top
and/or bottom faces (Bettini et al., 1994). Bettini et al. (1994) found there was no
signiﬁcant eﬀect of molecular weight on the ratio of relaxational and Fickian release
but coatings caused the tablets to exhibit Case-II release.
2.3.4 Siepmann model
The geometric and assumptions about mass transfer in the Peppas model have led
to developments of newer models such as the one developed by Siepmann et al
(Siepmann et al., 1999a,b). This model is based on Fick’s second law of diﬀusion
for a cylindrical geometry (Crank, 1975):
dc
dt
=
1
r
{
∂
∂r
(
rD
∂c
∂r
)
+
∂
∂θ
(
D
r
∂c
∂θ
)
+
∂
∂z
(
rD
∂
∂z
)}
(2.15)
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In the early Siepmann model, radial concentrations are neglected and the swelling is
assumed to be ideal and homogeneous throughout the entire tablet. Crucially, a per-
component diﬀusion coeﬃcient is used, which takes into account the concentration
of water within the polymer network (with a similar expression for the diﬀusivity of
drug):
D = D0exp
{
−βs
(
1− cw
c∗w
)}
(2.16)
Later versions of the model improve the accuracy by discretising the tablet into
concentric cylinders, so that swelling in the radial and axial directions can occur
independently in each layer, giving rise to a polymer density gradient within the
tablet (Siepmann and Peppas, 2001, 2000). This model has been successfully used
to ﬁt drug release proﬁles from hot melt extrudes (Verhoeven et al., 2009), small
ﬁlm-coated pellets (Muschert et al., 2009) and recently the model has been used to
predict release from KollidonTM tablets (Siepmann et al., 2010).
2.3.4.1 Modelling diffusion
The diﬀusion of water and drug through the swelling polymer gel is key to the
Siepmann model, which is based on Fick’s ﬁrst and second laws. In the simplest one
dimensional case, Fick’s ﬁrst law for steady-state one dimensional diﬀusion describes
the mass ﬂux J as:
J = −DdC
dx
(2.17)
The second law (non steady-state diﬀusion) can be derived from the changing mass
ﬂux:
dC
dt
= −dJ
dx
(2.18)
= D
d2C
dx2
(2.19)
Equation 2.19 assumes constant diﬀusivity and equimolar counter diﬀusion, that
is for a two component system, the diﬀusivity of component 1 in component 2 is
the same as component 2 in component 1. For diﬀusion in polymers, the diﬀusion
of water through the polymer is much faster than diﬀusion of polymer through
water and if volume were to be conserved, the diﬀusion of water would be limited
by the fact that “space” would need be created by the polymer diﬀusing in the
other direction before the water could diﬀuse in. This concept is the foundation
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of “Free Volume Theory”, which was originally used to describe the diﬀusion of
organic solvent through a polymer (Vrentas and Duda, 1977; Fujita, 1961). When
solvent molecules diﬀuse through a concentrated polymer solution, the migration of
molecules is impeded by the other polymer chains and can only move if there is a
void or hole available for them to move into (hence “Free Volume”). Two conditions
must be satisﬁed for movement to occur, one is that a void of suﬃcient size is next
to the molecule and the other is that there is suﬃcient free energy of the molecule
to move or jump into this void. The expression for the self diﬀusion of solvent
(component 1) is:
D1 = D01exp
[
−γ0(ω1Vˆ
∗
1 + ω2ξVˆ
∗
2 )
VˆFH
]
(2.20)
In Equation 2.20, γ0 is the overlap factor (as the same free volume is available to
more than one molecule), ωi and Vˆ ∗i are the mass fraction of i and speciﬁc free
volume of component i required for a movement or jump. The term VˆFH is the
average free volume per gram and ξ is the ratio of speciﬁc free volumes multiplied
by the molecular weight of components 1 and 2. This equation requires many terms
to be determined experimentally. A simpler Fujita-like version was proposed by
Siepmann, approximating the diﬀusivity of component 1 (water) through the swollen
polymer with the self diﬀusion coeﬃcient of water D1eq in fully swollen polymer, a
parameter beta1, the concentration of water in the polymer c1 and the equilibrium
concentration of water in the polymer c1eq :
D1 = D1eqexp
{
−β1
(
1− c1
c1eq
)}
(2.21)
The use of this expression shows good agreement with experimental data (Siepmann
et al., 1999a,b).
2.3.5 Modelling disentanglement
For many cellulose-based polymers, disentanglement is a slow process compared to
excipients such as lactose. For example, Chirico et al. (2007) noted that a fully
swollen polymer matrix of METHOCELTM K15M was still present in an aque-
ous dissolution cell after 5 days, although it should be noted that dissolution was
only allowed to take place in the radial direction. For lower viscosity polymers
(METHOCELTM K100LV), the dissolution can be much faster and aﬀect the re-
lease of the drug by erosion although for higher molecular weight polymers this
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eﬀect is diminished (Reynolds et al., 1998). For insoluble drugs, the polymer may
dissolve and “release” the drug from the point of view of the tablet, but it may not
necessarily be dissolved (van der Weerd and Kazarian, 2005), hence the polymer
ought to dissolve at a slower rate than that of the drug or the drug’s release will not
be controlled by the gel layer.
It is known that dissolution of the polymer occurs once the chains are suﬃciently
relaxed that they can disentangle themselves from the polymer matrix (Ju et al.,
1997). Narasimhan and Peppas (1996) proposed a reptation time, i.e. once the poly-
mer has reached disentanglement, it will take some time for it to leave the polymer
matrix. The reptation time is based on the molecular weight of the polymer and the
solvent viscosity. If a simple zero-order model is used for polymer dissolution (like
Equation 2.1), it would be incorrect to treat the dissolution constant as constant,
rather it should change over time (Narasimhan, 2001). Nonetheless, under condi-
tions where the hydrostatic forces are suﬃcient to pull the polymer chains from the
gel layer i.e. in ﬂow conditions, an erosion constant can be assumed (Kaunisto et al.,
2010).
2.3.6 Other models
Most recent models use variable diﬀusion coeﬃcients with Finite Volume systems,
solved numerically to model drug release (Barba et al., 2009a,b; Chirico et al., 2007;
Borgquist et al., 2006; Brazel and Peppas, 2000). As computing power has increased,
it has become feasible to move away from analytical solutions and simple models
with homogeneous component distribution towards explicit solutions generated by
discretising the tablet into small volume elements and applying mass transfer to each
volume element. The advantage of this method is ﬂexibility over tablet geometry,
component distribution and boundary conditions. An example of a non-swelling
model is that by Jia and Williams (2007), where real particle size distributions were
obtained from X-ray images and used as an input to the model, something which
would be impossible without the ability to explicitly deﬁne component distribution
within the tablet. The constituent granules of the tablet and the factors aﬀecting
their formation and dissolution can also aﬀect drug release (Štěpánek et al., 2009;
Štěpánek, 2008; Štěpánek et al., 2006; Štěpánek, 2004). The ﬁnite element method
(FEM) has been applied to model tablet swelling (Lamberti et al., 2011).
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2.4 Discrete Element Modelling
The Discrete Element Method (DEM) is widely used for modelling the behaviour of
granular materials, where the location, motion and shape of each element is explic-
itly deﬁned. Using this approach, DEM simulations can be used to investigate the
behaviour of powders in various processing units such as granular feeders or mixers
and obtain information about diﬀerent ﬂow regimes, internal stresses or residence
times, which would be diﬃcult or impractical to obtain using experiments (Ketter-
hagen et al., 2009; Anand et al., 2008; Lemieux et al., 2008). DEM can be used not
only for “passive” systems (granular ﬂows, mixing etc.) but also for coupled prob-
lems of particle movement and heat or mass transfer. Often a combination of DEM
is used simultaneously with other computational methods for example in ﬂuidized
bed reactors, where DEM models the motion of solid particles, and the ﬂuid phase
ﬂow is modelled using Finite Element Method (FEM) (Mansourpour et al., 2010;
Tsuji et al., 2008). In cases where heat and mass are to be transferred between
the continuous ﬂuid and the discrete solid phases, standard correlations such as the
Ranz-Marshall correlation can be used (Li et al., 2003).
When particle-particle heat or mass transfer is to be modelled, the question arises
as to what the appropriate formula for the interparticle ﬂuxes should be. Heat ﬂux
between particles has been extensively studied (Zhang et al., 2011; Batchelor and
O’Brien, 1977; Vargas and McCarthy, 2007; Wargas, 2002). A common approach has
been to use the Hertzian contact model, which deﬁnes the contact area between the
particles as a function of contact pressure, Poisson ratio and Young’s modulus. Other
algorithms for heat transfer can be used which are based on a geometrical approach
by considering the DEM particles as non-deformable spheres or discs, independent
of material properties. For particles in contact with each other, a small amount of
overlap can be permitted, and the length of the arc formed from the intersecting
discs (in 2D) can be used for the contact area (Zhou et al., 2009b, 2008; Wu and
Lee, 2000). Advances in this method can also describe temperature gradients within
the DEM particles, which is more accurate than the isothermal model since heat
ﬂux from diﬀerent contact points on the particle aﬀect the temperature distribution
within the particle (Feng et al., 2009, 2008; Siu and Lee, 2004). One problem with
these methods is that the calculated area often relies on material properties of the
DEM particles, which would not be applicable in this context. Secondly, these
methods rely on contacting or overlapping particles. Since the use of DEM in the
swelling code is to construct a deformable mesh, a more ﬂexible algorithm for mass
transfer is needed.
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2.5 Fourier Transform Infrared (FTIR)
spectroscopy
2.5.1 Fundamentals of infrared spectroscopy
Infrared (IR) radiation or infrared light is deﬁned as a region of the electromagnetic
spectrum whose wavelength lies between 700 nm and 1000 µm (Ball, 2003). The
infrared region, with respect to the rest of the electromagnetic spectrum, lies be-
tween visible light and microwave radiation (Figure 2.6). Infrared radiation is also
further subdivided into Far infrared (FIR), Mid infrared (MIR) and Near infrared
(NIR). It is common to measure the frequency of infrared radiation in units of re-
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Figure 2.6: The electromagnetic spectrum with expanded visible light section (Re-
drawn/adapted from Atkins and de Paula (2002)).
ciprocal wavelength or wavenumber (ν cm−1) rather than Hertz as wavenumber is
directly proportional to the photon energy. In this work, MIR will be used as it
corresponds to the fundamental vibrational modes of molecules (compared to FIR,
which corresponds to rotational modes and NIR which corresponds to the harmonics
of molecular vibrations). Infrared light is absorbed by molecules at the frequency
corresponding to the bending or stretching modes of their chemical bonds. The
mechanism is analogous to two masses connected by a spring, where there exists a
fundamental frequency of oscillation dependent on the masses themselves and the
stiﬀness of the spring. In molecules, only the correct frequency of infrared light (or
harmonics thereof) will be absorbed by a particular molecular bond, changing the
energy level at which it bends or stretches. Bonds between functional groups and
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the rest of the molecule are of particular interest as these will absorb at particular
frequencies, providing insight into the structure of the molecule. It is for this reason
that the region between approximately 400 and 2000 cm−1 is known as the ﬁnger-
print region. A molecule containing n atoms will have 3n− 6 degrees of vibrational
freedom (3n− 5 for linear molecules), so for CO2, the number of vibrational modes
is 4, which are shown in Figure 2.7. Not all vibrational modes are infrared active,
only those with a changing dipole moment will absorb infrared radiation hence the
symmetric stretch of CO2 (1388 cm−1) would not be seen in an infrared spectrum,
whereas the antisymmetric stretch (2349 cm−1) and bending modes (667, cm−1)
would. The bending modes are degenerate as they occur at the same frequency
although they can be separate when the CO2 interacts with other species (Kazarian
et al., 1996). Diatomic molecules such as CO and HCl are infrared active and have
only one vibrational mode, but gasses N2 and O2 are infrared inactive as the only
vibrational mode is a symmetric stretch. This is experimentally convenient as IR
spectra of samples will not be contaminated by air, provided that CO2 and water
vapour are removed.
Figure 2.7: Diagram showing the bending and stretching modes of CO2.
2.5.1.1 Infrared spectrometers
A traditional infrared spectrometer sends infrared radiation through a sample via a
diﬀraction grating and to a detector. In some optical arrangements, the beam is split
into two so that one can pass through the sample and the other through a reference
cell, enabling sample spectra to be acquired with the eﬀects of the reference cell re-
moved (Figure 2.8). Where a parallel set-up is not used, a spectrum of the reference
cell would be subtracted from the sample spectra. The use of a reference or back-
ground spectrum takes into account the non-uniform frequency of radiation emitted
from the source, absorption from the internal optics and absorption of materials
used in sample preparation.
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Figure 2.8: Diagram of a generic infrared spectrometer in transmission mode.
Figure 2.9: A diﬀraction grating causes the infrared light to be split into diﬀerent
frequencies, which are then selected using an aperture.
The detector can only detect the intensity of infrared radiation falling onto it
and not its frequency, hence the need for a diﬀraction grating whose purpose is to
ﬁlter speciﬁc frequencies of infrared radiation and measure each one in turn. The
diﬀraction grating causes diﬀerent frequencies of infrared light to be reﬂected de-
pending on the angle of the diﬀraction grating (Figure 2.9) and an aperture is used
to select the desired frequencies of infrared. The spectral resolution (i.e. the range
of wavenumbers per spectral data point) is determined by the width of the aperture
and the total acquisition time given by the speed of the detector. A narrow aperture
will select only a few frequencies but will produce higher resolution spectra at the
expense of scanning time whereas a wide aperture will produce a complete spectrum
quickly but of low spectral resolution. The diﬀraction grating can be upstream or
downstream of the sample. Modern spectrometers use an interferometer instead of
a diﬀraction grating. The Michelson interferometer is detailed in Figure 2.10. The
infrared beam passes through a beam splitter where one half is sent to a ﬁxed mirror
and the other half to a moving mirror where they are reﬂected and recombined in
the beam splitter and then sent to the sample. The movement of the adjustable mir-
ror causes a diﬀerence in path length and thus a phase diﬀerence between the two
beams so that when the beams combine, there will be constructive and destructive
interference (Smith, 1996). For a monochromatic IR source of wavelength ν passing
through the interferometer, there will be constructive interference when the position
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Figure 2.10: A Michelson interferometer where the beam splitting element divides
the beam into two, which are recombined with a phase diﬀerence de-
pending on the location of the movable mirror. The compensator en-
sures both beams pass through the same thickness of material (Re-
drawn/adapted from Atkins and de Paula (2002)).
of the moving mirror is at integer multiples of ν (i.e. 2ν, 3ν etc.) and destructive
interference at half the wavelength and multiples thereof (i.e. 1
2
ν, 3
2
ν etc.). For a
beam containing multiple frequencies passing through the interferometer, construc-
tive interference will occur when the path length of the two beams is identical and
constructive/destructive interference of diﬀerent frequencies will occur depending
on the diﬀerence in path lengths. By knowing the position of the moving mirror
(and therefore the path length diﬀerence) and the intensity of the IR striking the
detector (a plot of which is known as an interferogram) it is possible to use a Fourier
Transform to get an infrared spectrum (a plot of absorbance/transmittance against
wavenumber) and can be seen in Figure 2.11.
The main advantage of the interferometer is that all the radiation interacts with
the sample rather than selected frequencies as would be the case with the diﬀrac-
tion grating which produces a better signal to noise ratio, known as the Fellgett
advantage.
In order to get a spectrum of only the sample, the intensity of radiation from
the sample is ratioed with a background or reference sample to give a value of
transmittance (Eq. 2.22) where I and I0 are the intensities of radiation measured
with and without the sample, respectively. Absorbance is also commonly used and
is simply the negative log of transmittance (Eq. 2.23).
Transmittance =
I
I0
(2.22)
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Figure 2.11: Fourier transform applied to an interferogram to reveal a spectrum
(Smith, 1996).
Absorbance = − log10 Transmittance (2.23)
The resolution of the resulting spectrum for a spectrometer using an interferom-
eter is determined by how accurately the moving mirror can be adjusted. Higher
resolution spectra can have more noise due to the longer optical path length dif-
ferences required. The outer-lying areas of the interferogram have low signal and
therefore the signal to noise ratio is poorer. Beam divergence is also a problem as
diﬀerent parts of the beam will have travelled slightly diﬀerent distances, giving a
small error in the optical path length and thus poorer quality spectra. The problem
can be reduced using apertures, but this reduces the intensity of the signal. For
resolutions above 4 cm−1, apertures are not necessary (Smith, 1996).
2.5.2 FTIR Imaging
2.5.2.1 Attenuated total reflection (ATR)
Samples can be measured in a variety of ways, the simplest being transmission where
the IR radiation passes through the sample and some of its frequencies are absorbed.
Another mode is reﬂection, where a thin ﬁlm of the sample is deposited on a reﬂective
surface and the IR radiation reﬂects through the sample. Both these methods require
the sample to be thin enough to allow suﬃcient IR radiation to pass through but
thick enough to ensure signiﬁcant absorbance takes place. Samples analysed in
transmission may be sandwiched between two discs of IR transparent material (e.g.
NaCl or KBr) or ground together with KBr and pressed into a thin disc. In both
cases, care must be taken to ensure the materials are well mixed to avoid scattering
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Figure 2.12: ATR crystal with sample showing exaggerated evanescent wave.
eﬀects. FTIR spectroscopy with water-based systems in transmission is diﬃcult,
though not impossible due to the strong absorbance bands of water (Chan et al.,
2011; Coutts-Lendon et al., 2003).
A method known as attenuated total reﬂection (ATR) can be used to obtain in-
frared spectra without the diﬃcult sample preparation required by transmission and
reﬂection (Harrick, 1967). This method uses total internal reﬂection of the infrared
beam within an inverted prism or suitably shaped crystal to obtain spectra from a
sample placed on its surface. Total internal reﬂection occurs when radiation within
a high refractive index material reﬂects at the boundary between this material and
one with a lower refractive index. For this reﬂection to occur, the radiation’s angle
of incidence must be greater than the critical angle. At the interface, a small evanes-
cence wave penetrates into the other medium whose intensity decays exponentially
and the depth of penetration is dependent on the wavelength of infrared light. The
depth of penetration dp, where the intensity of the electric ﬁeld component of the
infrared light falls to e−1 of the maximum value, is given as:
dp =
λ
2πn1
[
sin2 θinc −
(
n2
n1
)2]0.5 (2.24)
where λ is the wavelength, n1 and n2 are the refractive indexes of the prism and
sample respectively and θinc is the angle of incidence. It is clear that the depth of
penetration is aﬀected by wavelength and the diﬀerence in refractive index of the
two materials. By adjusting the angle of incidence, it is possible to obtain spectra
from diﬀerent depths within the sample (Chan et al., 2008; Chan and Kazarian,
2007). When performing quantitative analysis, it is important to keep in mind that
changes in concentration of a component may change the refractive index of the
sample, altering the penetration depth.
For Mid-IR, the depth of penetration is typically between 1 and 5 µm. The
material used for the crystal is a trade-oﬀ between refractive index, size and other
2.5. FOURIER TRANSFORM INFRARED (FTIR)
SPECTROSCOPY 49
material properties such as pH resistance or IR transmittance. Table 2.3 shows some
of these properties where LWL is the lower wave length cut-oﬀ, n1 is the refractive
index of the crystal and dp is the depth of penetration at 1000 cm−1 for an angle of
incidence of 45°.
Table 2.3: ATR crystal properties (Pike Technologies, 2011).
Material n1 LWL (cm
−1) dp (µm) pH Range Hardness (kgmm−2)
Diamond/ZnSe 2.4 525 1.66 1-14 5700
Germanium 4 780 0.65 1-14 550
Silicon 3.4 1500 0.84 1-12 1150
ZnSe 2.4 525 1.66 5-9 120
It is important to ensure good contact between the sample and the crystal to ob-
tain good spectra, hence the hardness of the crystal is an important factor. Diamond
is suﬃciently hard such that in-situ compaction of pharmaceutical tablets is possible
(Wray et al., 2008; van der Weerd et al., 2004) and aqueous systems can be studied
without problems. It is also chemically resistant (unlike zinc selenide which can be
attacked by acids) and can withstand high temperatures and pressures (Kazarian
and Martirosyan, 2002).
2.5.2.2 Chemical imaging in ATR mode
Many spectrometers contain a single element detector that measures the average
absorbance of infrared light from the sample and if spatial information is desired,
the beam can be focussed and scanned across the sample either by scanning the
beam or moving the sample. This mapping technique takes a long time, Patterson
et al. (2006) found it took up to 7 hours to map a 1mm2 area by contacting an
ATR crystal across points on the sample and so this approach is not suited to
dynamic systems, where the sample changes over time. Contacting and removing
an ATR crystal can also cause the sample to shift or damage the surface. Linear
array detectors can be used, obtaining spectra from a line in the sample, although
this still requires mapping in the other direction to obtain two dimensional spatial
information (Zhou et al., 2009a). One disadvantage of mapping by scanning the
beam through the ATR crystal is that the optical path changes as the infrared is
focussed onto diﬀerent parts of the sample, causing a change in spatial resolution
(Patterson and Havrilla, 2006).
By using a array of detectors (a focal plane array or FPA detector), it is possible to
“image” the sample, where spatial and spectral information is recorded at the same
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ATR Crystal
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Figure 2.13: Diagram showing mirrors and lenses used to focus the infrared beam
onto the crystal.
Figure 2.14: Diagram showing surface measurement distortion arising from the angle
of the infrared beam (Chan and Kazarian, 2003).
time in two dimensions. A 64 × 64 FPA detector is therefore able to acquire 4096
individual spectra from diﬀerent locations on the sample. Unlike non-imaging ATR,
imaging ATR requires the beam to be focussed correctly so a set-up of multiple
mirrors and lenses is used (Figure 2.13).
Distortion of the image can occur as the beam enters and leaves the crystal at ap-
proximately 45°, causing a stretching of the image. This has been well documented
(Chan and Kazarian, 2003; Nakamura et al., 2000) and can be seen in Figure 2.14.
The distortion can be removed using corrective optics (Thompson and Poulter, 2006)
or by post-processing the imaging data in software. The maximum spatial resolution
that can be obtained using infrared light is determined by the Rayleigh criterion,
which relates the wavelength of radiation λ to the minimum distance between two
points (2r) that can be resolved (Eq. 2.25). It relies on the refractive index of the
crystal (n1) and the half angular aperture (θ). Due to optical aberration, the max-
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imum resolution can be 4 to 5 times lower than the theoretical minimum (between
5 and 20 µm for Mid-IR microscopy). Shorter wavelengths can be used to improve
resolution (NIR) but the penetration depth would be severely compromised. For
imaging pharmaceutical tablets, the granule sizes tend to be larger, so this resolu-
tion limit is not of concern.
r =
1.22λ
2n1 sin θ
(2.25)
The spatial resolution when imaging samples also depends on the required ﬁeld of
view which is determined by the apparatus used. When using an infrared microscope
in ATR mode (i.e. micro-ATR), imaging is possible, the ﬁeld of view is very small
(50×50 µm2) and for some samples, a larger ﬁeld of view is preferred so imaging with
a diamond Golden GateTM can be used (macro-ATR) (Chan and Kazarian, 2003).
If the sample being measured is not dynamic, mapping can be used simultaneously
with imaging, giving the spatial resolution comparable to that of micro-ATR but
the ﬁeld of view of macro-ATR (Chan and Kazarian, 2008).
2.5.2.3 Analysis of spectra
The area under each peak in an infrared spectrum is proportional to the concentra-
tion of its associated chemical bond through the Beer-Lambert law:
Absorbance = εalpC (2.26)
where ǫ is the molar absorptivity, lp is the path length (i.e. thickness of the sample)
and C is the molar concentration. In ATR mode, the path length l is known as the
eﬀective thickness de (Chan and Kazarian, 2007) and is given by:
de
λ
=
n2
n1
cos θinc
[
3 sin2 θinc − 2
(
n2
n1
)2
+
(
n2
n1
)2
sin2 θinc
]
(
2π
[
1−
(
n2
n1
)2]{[
1 +
(
n2
n1
)2]
sin2 θinc −
(
n2
n1
)2}[
sin2 θinc −
(
n2
n1
)2]0.5)
(2.27)
Numerical integration can be performed on the peak of interest for all spectra from
an FPA detector and the absorbance values plotted spatially, resulting in an ab-
sorbance image (Figure 2.15).
Each peak corresponds to a molecular vibration and if the composition of the
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Figure 2.15: Illustration of peak integration applied to all pixels of the FPA detec-
tor, resulting in a colour map corresponding to relative absorbance or
concentration.
sample is known (for example, the carbonyl band at around 1700 cm−1 may be
unique to one component in the sample), the concentration of that component can
be determined from the spectra. Applying this to all spectra from an FPA de-
tector, the resulting absorbance image can be seen as the spatial distribution of
that component. In a simple system, this type of univariate analysis can be used
as unique peaks can be found for all components within the sample. Where there
is signiﬁcant spectral overlap between components, multivariate analysis must be
used such as factor analysis. As mentioned previously, in ATR mode the depth
of penetration and thus the eﬀective thickness is dependent on wavenumber so the
true concentration may not be represented. This can be mitigated by measuring a
series of spectra for samples containing diﬀerent concentrations of the component
of interest and constructing a calibration curve. Imaging data sets already contain
many spectra so regression techniques such as partial least squares (PLS) (van der
Weerd and Kazarian, 2004a) can be used to correlate observed band intensities and
concentration.
Apart from concentration, it is possible to obtain information about the compo-
nents based on the peak shifts, where a peaks can move to higher or lower wave
numbers and change shape based on the interactions of that molecular vibration
with other molecules. For example, the carbonyl band in crystalline ibuprofen is at
1730 cm−1, but for ibuprofen in the amorphous phase in PEG, the band is wider
and is situated at 1705 cm−1 (Kazarian and Chan, 2003). In this way, infrared
spectroscopy can provide information on the molecular state or morphology of the
components.
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2.5.3 Applications of ATR-FTIR
2.5.3.1 General applications
The ATR approach requires little to no sample preparation compared with other
methods and the measurement of samples is non-destructive. Samples of limited
availability can beneﬁt from the ATR approach such as biological samples (Kraﬀt
et al., 2008; Kazarian and Chan, 2006; Wang et al., 2006; Parker and Ans, 1967)
or samples of cultural signiﬁcance (Ricci et al., 2007b). Forensic samples such as
ﬁngerprints (Ricci et al., 2007a) and residues from gel-tape can reveal trace ma-
terials such as narcotics (Ricci et al., 2006), which would otherwise be lost. The
non-destructive nature of ATR is particularly useful in this area as ﬁngerprint ev-
idence is not chemically altered (whereas dusting of ﬁngerprints preserves spatial
information but destroys the chemical information). The versatility of this method
allows insights into crude oil fouling of heat exchangers (Tay and Kazarian, 2009),
an expensive problem for the oil industry. Supercritical CO2 processes studied with
spectroscopy demonstrate the potential for supercritical CO2 in pharmaceutical pro-
cessing (Kazarian and Martirosyan, 2002; Kazarian et al., 1996) and other areas such
as dye impregntation (Kazarian et al., 1997). When imaging is not required, the ar-
ray detector can be used for high throughput screening, where multiple samples can
be studied simultaneously under varying conditions (Chan et al., 2007; Kazarian,
2007).
2.5.3.2 Pharmaceutical formulations
For this research, ATR-FTIR spectroscopic imaging of pharmaceutical tablets has
clear advantages over other characterisation methods due to the chemical speciﬁcity,
the minimal preparation required for ATR mode and in-situ compaction, enabled
by a custom compaction cell and a Golden GateTM accessory (Specac Ltd.) (Chan
et al., 2005; Kazarian et al., 2005; van der Weerd et al., 2004). Comparisons with
optical methods also show that ATR-FTIR imaging can show the true position of
various fronts within the tablet (Kazarian and van der Weerd, 2008; van der Weerd
and Kazarian, 2004b) rather than relying on information such as the change in the
refractive index of the polymer (Lamberti et al., 2011; Barba et al., 2009c; Colombo
et al., 1996; Gao and Meury, 1996; Pham and Lee, 1994) or the dissolution of a
colour changing component (Colombo et al., 1999a,b; Conte et al., 1993).
Studies of pharmaceutical tablet dissolution using ATR-FTIR spectroscopic imag-
ing have already been extensively conducted (Chan et al., 2007; Kazarian and Chan,
2006; Chan et al., 2005; Kazarian et al., 2005; Chan et al., 2003; Kazarian and
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Chan, 2003) and this approach can be combined with other analytical methods such
as downstream UV/Vis spectroscopy (van der Weerd and Kazarian, 2005, 2004a;
van der Weerd et al., 2004; van der Weerd and Kazarian, 2004b) to give information
on the release rate of components much like the USP as described in Section 2.2.
Information gathered using this approach can be used to verify and validate the
computer model by checking the progress of water ingress and the swelling and/or
dissolution of components within the tablet.
3 Experimental Methodology
3.1 Equipment
3.1.1 Imaging FTIR Spectrometers
The spectrometers used in this work were either a Bruker Equinox 55 or a Bruker
IFS 66, where both were combined with a macro chamber. The macro chamber was
used to house the Golden Gate or Pike VeeMax accessory and FPA detector. The
FPA detector used was a LN2 cooled 64×64 pixel FPA Mercury-Cadmium-Telluride
(MCT) detector, manufactured by Santa Barbara Focalplane. Careful alignment
of the internal optics ensured that the whole detector area was illuminated (Figure
3.1) and that the surface of the ATR crystal was in focus. The FPA detector was
set to ensure maximum dynamic range, i.e. the diﬀerence between the maximum
and minimum intensity of infrared is greatest. Images were taken every 2 minutes
resulting from 20 co-added scans (where SNR ∝ (no.scans 12 ) with a spectral reso-
lution of 8 cm−1. The FPA detector’s spectral range when working in Mid-IR was
4000 to 900 cm−1, where the lower value is a limit of the detector and upper value a
limit of the beam splitter. Depending on the type of Golden Gate used, the internal
optics would further limit the spectral range to approximately 1800 to 900 cm−1, i.e.
the ﬁngerprint region. A low-pass ﬁlter was required when a limited spectral range
was used to prevent spectral artifacts. Using a limited spectral range decreases the
scanning time which is beneﬁcial for fast-moving samples (Chan et al., 2011).
The detector is 14 bit and scans at roughly 2700 Hz (Figure 3.1), which for a
64×64 detector gives an overall data rate of approximately 18.45 MiB/s. Although
this is low by modern standards, the computer must be able to record the data and
apply the Fourier transform before the next scan of the moving mirror occurs. For
slower machines, spectra would be acquired in step-scan mode, where the mirror
is moved in discrete stages to acquire the interferogram. With modern computers,
continuous scan mode is possible, where the moving mirror does not need to stop.
This can introduce spectral artifacts if the exposure time of the FPA detector is too
long, in which case step-scan mode would be more appropriate.
Both imaging spectrometers used a purge air supply in order to displace water
55
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Figure 3.1: Live view of illumination of the FPA detector and its associated settings.
vapour and CO2 from the beam-path. The IFS-66 also used the purge gas supply
to run the air bearings in the interferometer, which are generally more accurate and
stable than mechanical bearing interferometers. The beneﬁt of this is to produce
higher quality spectra although at 8 cm−1 resolution as used in this work, the dif-
ference between air bearing and modern mechanical bearings is negligible (White,
1985). The purge gas supply also served to keep the background concentrations of
water vapour and CO2 constant as the background scan would be taken at the start
of the experiment before the tablet was imaged, hence the background would have
to be valid for long periods of time.
3.1.2 Single channel spectrometers
In order to measure single spectra, an imaging detector was not required, so a
Bruker Vector 22 or Alpha-P were used, both of which used deuterated triglycine
sulphate (DGTS) detectors. These detectors operate at room temperature thus have
a lower sensitivity compared to MCT detectors but produce acceptable results for the
measurement of pure-component spectra. The Vector 22 and Alpha-P operated in
ATR mode and had integral anvils to press the sample onto the crystal. The same
spectral resolution as used in imaging (8 cm−1) was used and as measuring pure
spectra was not time crucial, 64 scans were used. The stability of the background
was not an issue as the time taken for the background and sample scan would be a
few minutes compared to many scans over hours for the imaging experiments, so a
purge gas supply was unnecessary. The pure component spectra were used to ﬁnd
unique peaks for each component so that per-component absorbance images could
be produced from the tablet dissolution experiments.
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3.1.3 ATR accessories
Two ATR accessories were used in this work, an imaging Golden GateTM and a Pike
VeeMax II variable angle accessory. The imaging Golden Gate uses a diamond ATR
and contains corrective optics to account for distortion. The imaging area of the
imaging Golden Gate was found using a ﬁne wire mesh and polydimethylsiloxane
(PDMS) pressed onto the ATR crystal where the wire mesh had a grid pitch of 333
µm. The imaging area was approximately 670×610 µm2. As the live view mode
would also show absorbance, the optics and focus could be adjusted in real time.
This apparatus was used for the non-swelling formulations as the particular features
of interest would be particle size, degree of water penetration and degree of tablet
expansion (if any).
The VeeMax II variable angle accessory (Figure 3.3) was used with a zinc selenide
(ZnSe) ATR crystal for an expanded ﬁeld of view to study swelling tablets. A PDMS
grid was used to ﬁnd the imaging area of this accessory, which was approximately
7.9×5.3 mm2 (Figure 3.2). The use of zinc selenide meant tablets could not be
compacted in-situ so they were prepared ex-situ and then placed on the crystal.
The transparent perspex ﬂow cell (detailed in Section 3.1.4) was then pressed down
onto the tablet with just enough force to produce an image. The force used to press
the tablet onto the crystal did not need to be high as during dissolution, the gel layer
would prevent water seeping between the tablet and the crystal (van der Weerd and
Kazarian, 2004b). For swelling tablets, the features of interest were the formation
and expansion of the gel layer. A compromise was made for spatial resolution but
as the samples were homogeneous, this parameter was not critical. The VeeMax II
accessory was not designed for imaging, so changes in the angle of incidence would
change the imaging area and amount of aspect ratio distortion, but this could be
corrected in software. The angle of incidence was set low (approximately 42°) as
this gave a more uniform depth of penetration across the crystal.
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Figure 3.2: Absorbance image for PDMS grid on ZnSe ATR crystal with cell size
720×1008 µm2.
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(a) (b)
Figure 3.3: The Pike VeeMax II variable angle accessory (a) with a perspex ﬂow cell
(b).
3.1.4 Flow cells
Two diﬀerent ﬂow cells were considered, the in-situ compaction and ﬂow-through
cell as used by van der Weerd and Kazarian (2004a) (Figure 3.4a) or a transparent
perspex cell (Figure 3.4b) which allows visual monitoring of the tablet as it dissolves
(Velasco et al., 2011; Kazarian and van der Weerd, 2008). The in-situ compaction
cell consisted of a solid block, threaded die and water inlet/outlet pipes. The rub-
ber gasket was placed around the ATR crystal before the solid block was fastened
to the top plate surrounding the diamond ATR crystal (Figure 3.5a). For in-situ
compaction, the threaded die was wound down until it was in intimate contact with
the crystal. A stainless steel punch, situated in the centre of the threaded die was
removed and the tablet powders (pre-mixed in the desired weight fractions) were
poured into the threaded die. The punch was then replaced, the Golden Gate arma-
ture lowered and a torque screwdriver used to control the compaction force (Figure
3.5b). The threaded die was then raised independently of the punch, exposing the
tablet and the water inlet and outlet channels (Figure 3.5c). The ﬂow cell was de-
signed so that the compacted tablet would cover half the diamond, leaving the other
half exposed so that the tablet/water interface can be imaged.
For the perspex cell, the tablet was compacted ex-situ before being carefully placed
on the diamond or ZnSe crystal. A rubber gasket was placed around the tablet and
the perspex cell either fastened to the plate using four surrounding screws when
using the imaging Golden GateTM , or pressed down using an armature for the Pike
accessory. In this conﬁguration, special care would be needed as the perspex cell
would need to compress the gasket suﬃciently to stop water leaks and also press
the tablet onto the ATR crystal (Figure 3.5d) without cracking the cell or the ATR
crystal. Using the live view mode, it was possible to view the position of the tablet
and the eﬀect of increasing force. The advantage of the perspex cell is that tablet
dissolution can be seen visually as well as imaged.
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Figure 3.4: Diagrams of the Golden GateTM with in-situ compaction cell (a) and
perspex ﬂow cell (b).
(a) (b)
(c) (d)
Figure 3.5: Photographs of the in-situ compaction and ﬂow-through cell on the top
plate (a) and with armature lowered for compaction (b). Subﬁgures (c)
and (d) show the underside of the ﬂow cell with rubber gasket and the
transparent perspex dissolution cell respectively.
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3.2 Tablet preparation
3.2.1 Materials
The non-swelling tablets used polyethylene glycol (PEG) 4000 (supplied by Fisher
Chemicals) as the excipient and nicotinamide (supplied by Sigma-Aldrich) as the
drug. PEG 4000 was chosen as it does not swell signiﬁcantly and can be compacted
so that no signiﬁcant water penetration into the tablet would occur, an assumption
made in the non-swelling model. Nicotinamide was used due to its high solubility
and therefore its release would be limited by the excipient rather than its own
dissolution kinetics. Particles were ground and sieved to below 90 µm to minimise
heterogeneity upon compaction. Pure component spectra are shown in Figure 3.6.
The integration ranges used for PEG, nicotinamide and water were 1313-1261,
1400-1385 and 1708-1580 cm−1 respectively. Images based on the distribution of
integrated absorbance between 1708-1580 cm−1 show the distribution of both water
and nicotinamide.
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Figure 3.6: Pure component ATR-FTIR absorption spectra for PEG, nicotinamide
and water.
The swelling tablets used pure hydroxy-propyl methylcellulose (HPMC) K100
Premium LV (supplied by Colorcon, Dow Chemicals). The HPMC is classiﬁed as
low viscosity (having a viscosity of 0.08-0.12 Pa s in water at 20 °C) hence it would
swell and dissolve relatively quickly compared to higher viscosity HPMC (The Dow
Chemical Company, 2000). The spectra for HPMC and water are shown in Figure
3.7 and the integration range used for HPMC was 1150-1000 cm−1.
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Figure 3.7: Pure component ATR-FTIR absorption spectra for HPMC and water.
3.2.2 Compaction
Powder mixtures containing the required fraction of components were compacted
using a small compaction cell to produce tablets of 3 mm diameter and approxi-
mately 10 mg. Compaction was performed using an Enerpac piston at a pressure of
300 MPa for both types. It was noticed that whilst the HPMC would compress well,
the PEG would sometimes extrude out the base of the compaction cell, requiring
that part to be removed with a razor (Figure 3.8). The extruded PEG was removed
with a razor, also ensuring that the tablet base was ﬂat so as to form good contact
with the ATR crystal. The high compaction pressure ensured that the non-swelling
formulations would form a continuous matrix as PEG particles can fuse at high
pressures (Larhrib et al., 1997).
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Figure 3.8: Close-up optical image of PEG and nicotinamide tablet. The PEG forms
a continuous matrix with a small amount of extrusion at the base, which
is carefully removed prior to dissolution.
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3.3 Tablet dissolution
For the non-swelling formulations, the imaging Golden GateTM and in-situ com-
paction cell were used, where the tablet would be compacted ex-situ then carefully
placed into the cell. The ATR diamond plate was maintained at 25 °C through
the use of its heating controller. A syringe pump was used to push distilled water
through the ﬂow cell at a rate of 1.125 mlmin−1. During initial dissolution tests,
it was noticed that the dissolved nicotinamide could saturate the UV/Vis detector.
Increasing the ﬂow rate could mitigate this but introduce further problems of tablet
erosion. It was decided that a secondary pump should be added to the system to
dilute the eﬄuent stream before passing it through the UV/Vis detector (Figure
3.9) which would also have the beneﬁt of removing air bubbles from the stream
(which cause large spikes in the UV/Vis results). The UV/Vis was set to measure
absorbance at 260 nm.
UV/Vis HPLC Pump
Syringe pump
Flow Cell and ATR crystal
Reservoir
Air trap
x ml/min
n.x ml/min
(n > 1)
Air outlet
Effluent
Figure 3.9: Flow cell arrangement with downstream mixing and air removal.
The swelling tablets were dissolved using the VeeMax II accessory and the perspex
ﬂow cell at the same ﬂow rate as used with the non-swelling tablets. The UV/Vis
spectrometer was not used as HPMC does not absorb UV strongly in the concen-
trations within this system. The ﬂow cell was connected in a loop with the reservoir
(2 L) as it was assumed with a large volume of water, the dissolved HPMC will not
alter the dissolution kinetics of the tablet (whose maximum concentration would be
around 5× 10−3kgm−3).
4 Computational Methods
This chapter contains the mathematical description of both the non-swelling and
swelling models (which are published or submitted (Kimber et al., 2012, 2011a,b))
as well as a comparison between optimisation methods and details on the hardware
and software used in this work.
4.1 Non-swelling model
The simulation of dissolution and drug release from non-swelling tablets is based on
discretising the tablet into volume elements or voxels on a Cartesian grid and the
mass transfer between these voxels solved over small time steps. Although many
tablets use swelling polymers as their main excipient, simulating drug release from
non-swelling tablets can still give useful information as to the eﬀect of parameters
such as particle size distribution, external ﬂow conditions and the component phys-
ical properties and the model developed in this work was used to investigate these
areas.
4.1.1 Tablet discretisation
For the non-swelling model, the tablet contains two components (A and B) which
represent the drug and an excipient. The tablet is discretised in 2D. Each voxel
initially contains a given amount of component A and B, characterised by the com-
ponent phase volume fractions φi ∈ 〈0; 1〉 (Kosek et al., 2005). A volume fraction
of unity corresponds to a completely solid voxel whereas voxel of zero contains only
liquid phase and in principle, any number of components can be included. Compo-
nents within the tablet can be homogeneously dispersed (each voxel containing the
same volume fraction of each component), randomly dispersed (each voxel contain-
ing either A or B in a random fashion) or distributed randomly but with discrete
regions of A and B. The intermediate case is most interesting as it provides the
ability to investigate the eﬀect of particle or agglomerate size on drug release.
The distribution of components is generated using a randomisation algorithm
followed by Gaussian smoothing. This is achieved by generating a matrix of random
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Figure 4.1: Tablet randomisation, smoothing and clipping.
numbers uniformly distributed between 0 and 1 where the matrix is of the same
dimension as the computational domain and the random numbers correspond to the
volume fractions of component A. Component B is not speciﬁed as it is ﬁlled in
later by virtue of the fact that for binary tablets, φB = 1−φA. Gaussian smoothing
is applied to the random voxels (Eq. 4.1), which for each voxel, takes a distance
weighted sum of the surrounding volume fractions, eﬀectively smoothing the random
noise. The Gaussian smoothing is given by:
φnewi =
∑
j:dij≤Lc
exp(−d2ij/L2c)φoldj (4.1)
In the equation above, dij is the Euclidean distance between points i and j on the
discrete grid.
The distance from the voxel from which the surrounding volume fractions are
summed is the correlation length Lc, so that a large correlation length will produce
a larger smoothing eﬀect. The weighting function is an exponential function based
on distance, hence the name Gaussian smoothing. All voxels outside the tablet
radius are then set to zero. To turn the remaining smoothed voxels into discrete
particles, a cut-oﬀ value is used so that voxels whose volume fraction is above this
value are set to a value 1 and those below are set to 0 (e.g. for cut-oﬀ of 0.4, values φ
< 0.4 are set to 0 and ≥ 0.4 are set to 1). For a tablet containing two components, A
and B, the cut-oﬀ point is determined iteratively such that the total volume fraction
of all the voxels representing component A meets a speciﬁed value. Component B
is then used to ﬁll the remaining empty voxels inside the tablet radius (Figure 4.1).
Diﬀerent distributions can be generated using a diﬀerent random seed values and
Figure 4.2 shows the eﬀect of increasing volume fraction and correlation length for
a single random seed value.
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Figure 4.2: Eﬀect of increasing correlation length and volume fraction of component
A.
4.1.2 Mass transfer equations
The dissolution of each component i at the solid-ﬂuid interface is modelled as a
ﬁrst order rate process and its subsequent diﬀusion in the surrounding ﬂuid phase
is modelled using Fick’s second law with a variable diﬀusion coeﬃcient:
∂ci
∂t
= −∇ · (−Di∇ci) + si i = A,B (4.2)
where
si(x) =

ki(c
sat
i − ci(x)) ∀x: φi(x) > 0
0 otherwise
(4.3)
i.e. the source term is nil if the i-th component is not present in a given voxel as a
solid. The diﬀusion coeﬃcient is related to the overall solids volume fraction via
Di = Di0(1−
n∑
i=1
φi)
βi (4.4)
This means that diﬀusivity is zero for a completely solid voxel and equal to the
component’s bulk diﬀusivity when the voxel contains only the ﬂuid phase. The
parameter β can be used to account for non-linearities. This has the eﬀect of ac-
counting for porosity within a voxel and it has been used to approximate diﬀusivity
through porous material in the past (Coelho et al., 1997).
The diﬀusion of each component is coupled with a local change of its phase volume
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fraction in the tablet via the evolution equation
∂φi(x)
∂t
= −si(x)
ρi
(4.5)
The local rate of dissolution si is given by Equation 4.3. In the numerical implemen-
tation of the above equations, the volume available to the liquid phase is ﬁxed as
the full dimension of the voxel. This avoids the problems of deﬁning concentration
within a changing volume, where the concentration of a component is dependent on
the volume fraction of the solid phase. The model makes the assumptions that the
saturated concentration of each component, csati , is not dependent on the current
concentration of other solutes and that dissolution only occurs in a voxel if at least
one neighbouring voxel is devoid of solid. The mass of solid that can dissolve in a
single time step is limited, such that when ki is large, the amount that can dissolve
is limited by the diﬀerence between csati and ci within that voxel or the amount of
remaining solid phase.
Water ingress into the tablet is therefore limited by the dissolution rate of the
solid phase (water does not diﬀuse through the tablet structure as such). If water
could penetrate freely such that the whole tablet is “wet”, the overall dissolution
rate of a component from the wet core would be slow due to the low diﬀusivity and
nearly zero internal concentration gradients but could still be appreciable for highly
soluble, quickly diﬀusing species. Limiting the rate of water ingress is therefore
important and the previous assumption is valid for highly compacted formulations
where capillary ﬂow is negligible. In other cases, a rate expression for water ingress
could be used.
4.1.3 Numerical method
The diﬀusion of components between two voxels in 2D is described by Fick’s second
law and can be represented for voxel i, j as forward-diﬀerence in time and central
diﬀerence in space:
ct+∆ti,j − cti,j
∆t
= D
[
cti−1,j − 2cti,j + cti+1,j
∆x2
+
cti,j−1 − 2cti,j + cti,j+1
∆y2
]
(4.6)
and as ∆x = ∆y then Equation 4.6 can be simpliﬁed to
ct+∆ti,j − cti,j
∆t
= D
[
cti−1,j + c
t
i+1,j + c
t
i,j−1 + c
t
i,j+1 − 4cti,j
∆x2
]
(4.7)
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For stability, the value of ∆t must be chosen carefully and is based on the voxel
dimension, ∆x. The maximum concentration gradient for any c is obtained when
the concentration in voxels surrounding voxel i, j are zero, so Equation 4.7 can be
simpliﬁed
ct+∆ti,j = D∆t
−4cti,j
∆x2
+ cti,j (4.8)
and the new concentration ct+∆ti,j should never be less than zero, so applying this
condition and dividing through by cti,j, Equation 4.7 becomes
D∆t
−4
∆x2
+ 1 > 0 (4.9)
or rearranged:
∆x2
4D
>∆t (4.10)
With this knowledge, it is possible to adjust the time step dynamically (using the
maximum diﬀusivity for the entire system if it changes with time), enabling tablet
dissolution to be simulated with the lowest number of iterations thus decreasing the
computational time required. The dissolution of material into the liquid phase is
subject to certain conditions which were brieﬂy outlined in Section 4.1.2. For the
numerical implementation, these are:
si = min
(
si,
φρ
∆t
,
csati − ci
∆t
)
(4.11)
This is necessary to make sure that the solid volume fraction never becomes negative
or the liquid phase concentration never exceeds the saturated concentration, the
latter of which can be avoided by using a small time step.
4.1.4 Boundary conditions
In order to evaluate the cumulative dissolved mass of each component as function of
time, a per-component boundary was situated at a distance δi from the solid phase
(i.e. the nearest point where φi > 0). This represents the diﬀusion boundary layer
thickness for that particular component and it can be determined either from mass-
transfer correlations or experimentally from FTIR images. The value of δi can be
found using the Sherwood number, where δi = 2rt/Sh where rt is the tablet radius
at time t. In this work, the Hilpert correlation (Hilpert, 1933) was used to ﬁnd the
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Sherwood number (Eq. 4.12) where Re = ρU2rt/µ and Sc = µ/ρD.
Sh = 0.989Re0.33Sc
1
3 (4.12)
The values for viscosity can be obtained from literature, measured or in the case of
diluted systems, assumed to be close to that of water. As the tablet dissolves and the
solid-liquid interface recedes, the boundary layers follow it. Components that have
diﬀused across their boundaries are considered “released” and their concentration at
and beyond their boundaries is set to zero. The simulation of single tablet dissolution
ends when at least 95 % of all components have been released.
Figure 4.3 shows a typical set of release proﬁles along with 2D concentration maps
for component B. Although a release curve provides full details about the course of
dissolution, it is often practical to express the results of a dissolution experiment by
a few or a even a single numerical value - particularly when conducting parametric
sensitivity studies. For this purpose we use the integral release times t10, t50 and
t90, deﬁned as the time required for 10 %, 50 % and 90 % of a given component
originally present in the tablet to be released.
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Figure 4.3: Example release proﬁle for a binary tablet (rt = 3 mm) and concentra-
tion snapshots for the dissolution of component B. Volume fraction of
component A was 50% and correlation length was 66 µm. Boundary
conditions were set to the square edge of the domain.
4.2. SWELLING MODEL 69
dz
Equivalent
hexagon
r
t
r
i
Figure 4.4: Diagram showing a tablet discretised into cylindrical DEM elements.
4.2 Swelling model
Unlike the non-swelling case, where the tablet was discretised into a set of cubic
volume elements, the tablet in the swelling cases is discretised into a set of cylindrical
discrete volume elements (DEM) (cf. Section 4.2.1 for details on the DEM method),
where each element contains a mass of one or more components (Figure 4.4). As
components diﬀuse or dissolve into or out of the elements, the radii of the particles
can change, giving rise to swelling or dissolution. The swelling model consists of two
main sections, one is the mass transfer between elements, which is governed by the
mass transfer equations and the other is the movement of the particles themselves,
which is solved using DEM code. These parts are decoupled so that the particles are
always at rest and not overlapping when mass transfer occurs, and the DEM code
is called only after single mass transfer time step to ﬁnd the new particle positions
as a result of swelling. The time used to ﬁnd the new particle equilibrium positions
is not added to the mass transfer time, making the DEM code independent of the
mass transfer section. All that is required of the DEM code is to ﬁnd the equilibrium
positions of the particles before the next mass transfer time step. The other crucial
diﬀerences between the non-swelling and swelling models are the calculation of the
mass transfer area between DEM particles and the behaviour of edge particles, which
are addressed in subsequent sections. It is important to note that the word “particles”
used in the sections relating to the swelling model is referring to the cylindrical DEM
volume elements rather than physical excipient or drug particles. Depending on its
absolute size and required discretisation, each physical particle can be made up of
many DEM particles, and similarly, a single DEM particle may represent a cluster
of several physical particles. The overall simulation procedure is shown in Figure
4.5, the details of which are explained in the subsequent subsections.
4.2.1 Discrete Element Method (DEM)
The Discrete Element Method (DEM) is widely used for modelling the behaviour of
granular materials, where the location, motion and shape of each element is explic-
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Figure 4.5: Diagram showing the swelling program structure.
itly deﬁned. The simplest form of DEM is in 2D, where particles are represented by
circles although the extension to 3D spheres is straightforward. The particle diame-
ters and size distribution are characteristic of the granules to be modelled. Particles
experience forces which are either global, such as gravity or local, such as collisions
with other particles or the container walls. The forces resulting from particle inter-
actions or collisions with the container walls can be decomposed into normal and
tangential forces. The normal force is governed by the elastic and plastic properties
of the materials and the tangential force, by the friction between the contacting
surfaces. Other forces such as adhesion and electrostatic can be added depending
on the materials in question. Once the forces are known, the particle velocities and
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positions over time can be found via integration of Newton’s second law:
Fi = mi
d2xi
dt2
(4.13)
4.2.2 Tablet discretisation
Closely packed cylindrical elements of equal radius occupy more area than the sum
of their individual areas due to their hexagonal packing, which means when a tablet
is discretised into DEM particles, there would be a diﬀerence between the volume
of the particles and the space they occupy. For a set of n× n 2D DEM elements of
radius ri bounded by a box (Figure 4.6), the area of the bounding box Abox is:
Abox = (2rin)(h(n− 1) + 2ri) (4.14)
and the area of all DEM particles is:
ADEM = πr
2n2 (4.15)
substituting for h, the ratio between the areas is:
Abox
ADEM
=
2
√
3
π
− 2
√
3
nπ
+
4
nπ
(4.16)
It is clear that for large values of n, the ratio is simply 2
√
3
pi
so the for a given particle
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of radius ri and height dz , the volume Vi of the equivalent hexagonal prism is:
Vi = 2dz
√
3r2i (4.17)
Each DEM particle represents part of an overall continuum and is characterised
by the mass of polymer mpi , water m
w
i or drug m
d
i it contains so the volume and
by extension, radius of each particle can also be derived from the total mass of
components within the particle (Eq. 4.18).
Vi =
mpi
ρp
+
mwi
ρw
+
mdi
ρd
(4.18)
Equation 4.18 could also include a term∆Vmix accounting for the non-ideal mixing
if required. However, in this work the additivity of molar volumes is assumed.
During each time step, the radius of each particle is adjusted depending on the
mass it contains so that polymer particles absorbing water can swell and dissolving
particles can shrink.
4.2.3 Determination of mass transfer area
The mass ﬂow between two volume elements i and j (DEM particles at positions
xi and xj) depends on the mass transfer area (Ai,j) and mass transfer distance
(di,j = ||xi − xj||) between them. The mass transfer area for cubic and a regularly-
packed DEM particles is well deﬁned, the latter being one side of the equivalent
hexagonal prism Ai,j =
√
3
2
ridz but when two DEM particles have diﬀerent radii,
the mass transfer area becomes more diﬃcult to calculate. One method is to use
Voronoi tessellation (the dual of which is the Delaunay tessellation) and from this,
the mass transfer area can be found (Figure 4.7). The Voronoi vertices are simply
the points which are equidistant to three or more particle centres. Unfortunately
the Voronoi tessellation underestimates the mass transfer area when ri ≫ rj and
how degenerate cases are handled depends on the algorithm used (a degenerate case
is where the Voronoi vertex is equidistant to more than three particles, as shown in
Figure 4.8b). Two other methods can also be considered, these being the “Common
neighbours” and “Tangent” methods. The Common neighbours method is based on
the mid-points between the contacting particles i and j along with their neighbours.
This method is the most accurate but inevitably more computationally intensive
as information about the neighbours of neighbours must be known. It also fails
where there is no particle-particle contact of the neighbours, such a degenerate case
is shown in Figure 4.8a.
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Mass transfer distance
Mass transfer area
Figure 4.7: Diagram showing the Delaunay and Voronoi tessellations between DEM
particles. The Delaunay lines (blue) are the mass transfer distances,
whilst the Voronoi lines (red) are the basis for mass transfer area. In
2D, the Voronoi lines are extruded to the height of the DEM particles,
providing the mass transfer area.
?
i j
(a) (b)
Figure 4.8: Example of degenerate cases for the Common neighbours method (a)
where due to a particle bridge the second vertex cannot be calculated
and the Voronoi tessellation (b) where the red vertex is equidistant to
more than three particles.
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Figure 4.9: Graphical representation of the mass transfer area between particles i
and j according to the Tangent method.
A novel method that was developed is the “Tangent” method (Kimber et al.,
2011a), where the mass transfer area is deﬁned by the intersection of tangents drawn
from the edge of one particle to the centre of the other and vice-versa. The mass
transfer area Ai,j is illustrated in Figure 4.9 and derived as follows:
Ai,j = 2dp1,p2dz (4.19)
dp1,p2 =
di,j
tan θ1 + tan θ2
(4.20a)
θ1 = cos
−1(ri/di,j) (4.20b)
θ2 = cos
−1(rj/di,j) (4.20c)
The main advantages of this method are its speed and simplicity, as the only
information required are the interparticle distances (which would be known from
DEM calculations) and the particle radii. This method can be run in parallel without
the risk of race conditions and can also be used for cases when particles are not
contacting but are close enough to each other for mass transfer to occur. The only
degenerate case is when one particle centre is inside the radius of another one, as
θ1 or θ2 become undeﬁned. A comparison for all three methods is shown in Figure
4.10 where it is clear the Voronoi vertices are too far inside particle i, the Common
neighbours is the most accurate and the Tangent method is slightly less accurate
but more robust and faster to run than the other two methods. Detailed validation
of the method and evaluation of its accuracy for both steady-state and transient
diﬀusion will be discussed in Sections 5.2 and 5.3.
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Figure 4.10: Comparison between the Voronoi, Common neighbours and Tangent
methods for calculating the mass transfer area between two DEM par-
ticles.
4.2.4 Boundary conditions
For the non-swelling model (cf. Section 4.1.4), the volume elements around the
tablets were assumed to be ﬁlled with water and a concentration boundary layer
existed within those elements whose thickness was based on the Hilpert correlation.
For the swelling model, there is no concentration boundary layer as it is assumed
that the mass transfer within this layer would be much faster than the mass transfer
within the tablet. It was proposed that some DEM particles surrounding the tablet
would contain only water, so that material diﬀusing out of the tablet would have
somewhere to go (although any material diﬀusing into them would be instantly
removed and counted as released) but there were two reasons why this approach
was not ﬁnally adopted. Firstly, it would have been necessary to have a suﬃcient
number of water particles around the tablet at the start so that once the tablet had
expanded, there would still be water particles surrounding the entire tablet. The
number required would need to be calculated before-hand or checked throughout
the simulation and unless many particles were used, there would be no guarantee
of total water coverage at all times. Secondly, the computational overhead of this
would be large, as many particles would not be partaking in any swelling but their
movement and positions would still need updating as the tablet expanded.
Instead, the water boundary layer was removed entirely and any particles on the
edge of the tablet were assumed to have pure water contacting them. Material
within the edge particles would diﬀuse or dissolve out and the bulk concentration of
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the surrounding region would have a ﬁxed value. To achieve this, an edge detection
algorithm was written, which required three parameters: the free area calculated
according to:
Afi = A
max
i −
∑
j 6=i
Ai,j (4.21)
which is the mass transfer area not occupied by neighbouring particles, the maximum
free area Amaxi :
Amaxi =
12√
3
dz ri (4.22)
which is the maximum possible mass transfer area the particle could have and the
free area fraction A∗, which is a numerical parameter so that if A
f
i
Amaxi
> A∗, a particle
can be considered on the edge.
The edge detection algorithm uses particle binning, whose purpose is to reduce
the computational work and eliminate false positives. The domain is divided into a
grid and each particle centre falls within one of the cells or bins. Each bin is then
checked recursively with its nine neighbours to see if that neighbouring bin is empty.
When a bin containing at least one particle is adjacent to an empty bin, the particles
within that bin have their free area and maximum free area checked. Those particles
which satisfy the condition A
f
i
Amaxi
> A∗ are marked as edge particles and thus mass
transfer to the bulk can occur. Figure 4.11 shows a graphical representation of the
particle bins and the detection of edge particles. The bins must be large enough
to fully contain the largest particle (otherwise empty bins would appear inside the
tablet) but small enough so that when a bin adjacent to an empty bin is found, not
many particles need to be checked.
4.2.5 Mass transfer equations
4.2.5.1 Water diffusion
The mass transfer of components between DEM elements is similar to the non-
swelling case, but due to the nature of swelling polymers, a new parameter, the
swelling ratio is deﬁned:
φi =
mwi
mwi +m
p
i
(4.23)
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Figure 4.11: Diagram showing edge detection method and free area of edge particles.
Related to this are the disentanglement threshold φd and the equilibrium water mass
fraction φ∗. The disentanglement threshold is the mass fraction of water above which
the polymer itself starts to disentangle and the equilibrium water mass fraction limits
the amount of water that can diﬀuse into the polymer. The concentration of water
cwi within a polymer particle is therefore dependent on φ
∗ so that cwi = ρw when
φi = φ
∗ (Eq. 4.24).
cwi =
mwi
mpi
ρw(1− φ∗)
φ∗
(4.24)
The mass balance of water in each DEM particle is given in by:
dmwi
dt
=
∑
j 6=i
Ai,jD
w
i,j
cwj − cwi
ri + rj
+ Afi
Dwi
2ri
(ρw − cwi ) +
mwi
mpi
dmpi
dt
(4.25)
containing terms for the diﬀusion of water between particle i and its neighbours j,
the uptake of water for edge particles and the release of water due to polymer disso-
lution. The release of water due to polymer dissolution is based on the assumption
that as polymer chains disentangle from the particle, the water that was associated
with them is also released, thus maintaining a constant water mass fraction in the
particle.
The diﬀusion coeﬃcient of water between particles i and j is based on a Fujita-
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type exponential expression (Siepmann and Peppas, 2001) and is given by:
Dwi,j = D
w
min + (D
w
max −Dwmin)min
(
cwi
ρw
,
cwj
ρw
)β
(4.26)
The minimum diﬀusivity Dwmin is the diﬀusivity of water through dry polymer and
Dwmax is the diﬀusivity of water through fully swollen polymer gel at φ
∗. The term β
is a measure of the non-linearity of the transition between these two limiting values.
4.2.5.2 Polymer dissolution
Once the water mass fraction in the polymer has reached the disentanglement thresh-
old φd, a ﬁrst-order dissolution expression is used to characterise the polymer disso-
lution. It should be noted that for polymer dissolution to occur, φd < φ∗. As is the
case for water absorption, the free area Afi is used with a dissolution rate constant
kdiss to obtain the overall polymer mass transfer and so the polymer mass balance
is:
dmpi
dt
=

0 if φi < φ
d
−kdissAfi
(
mpi
Vi
− cpbulk
)
if φi ≥ φd
(4.27)
where in this work, the concentration of polymer in the bulk solution cpbulk = 0.
4.2.5.3 Evolution of a single DEM particle
By solving equations 4.25 and 4.27 for a single isolated DEM particle, it is possible
to observe how the particle radius changes over time as a result of water uptake
(given as the mass fraction φ) and polymer loss once φ reaches the disentanglement
threshold (φd). Figure 4.12 shows water uptake and polymer loss, where the radius
increases when φ < φd, dissolution begins once φ = φd and the polymer mass mp
starts to decrease. The parameters used for calculating Figure 4.12 are: ri = 5 ×
10−5m, φd = 0.8, φ∗ = 0.95, Dmin = Dmax = 1× 10−11m2s−1, kdiss = 4× 10−8ms−1.
The water uptake and thus radial expansion rate slows until the dissolution rate of
the polymer exceeds the rate of expansion. At that point the particle radius begins
to decrease. With many particles behaving in this way, the swelling and dissolution
of a whole tablet is possible.
4.2.5.4 Calculation of inter-particle forces
Between each mass transfer time step ∆t, the equilibrium positions xi of n particles
are obtained so that they are in close contact. This is achieved by applying Newton’s
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Figure 4.12: Single DEM particle swelling and dissolution. The black dashed line
denotes the onset of polymer dissolution, where φ > φd.
Laws of motion to each DEM particle. Overlapping particles interact using a linear
spring method with damping, and these forces are resolved over virtual time steps
∆τ independent to those of mass transfer until the maximum force experienced by
any particle falls below a set threshold. Firstly, the inter-particle repulsion force
F
rep
i,j is given by:
F
rep
i,j =

0 if di,j > (ri + rj)−krep ri+rj−di,jri+rj xi−xj||xi−xj || if di,j < (ri + rj) (4.28)
where di,j is the distance between the centres of particles i and j. To maintain a
close packed structure, a small global attractive force Fgravi given by:
F
grav
i = −
xi − xc
||xi − xc||F
grav (4.29)
acts on all particles to pull them towards the centre of the domain xc, where this
force is suﬃcient to ensure shrinking particles remain in contact with the main body
of particles but small enough to prevent signiﬁcant particle overlap. Such a force is
only correct for cylindrical tablets and ideally a particle attraction force should be
used instead so that tablets of any geometry can be simulated but an attractive force
raises further complications. These centre around the stability of the simulation and
the formation of particle structures from a swelling tablet due to the cut-oﬀ distance
over which the attractive force operates. By ensuring the gravitational force is small,
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as the outer particles dissolve and shrink, they are gently moved into contact with
the bulk of the tablet, but not so much as to pull the smaller particles into the tablet
or cause large shifts in tablet structure.
A damping force based on particle velocities ui is also used to remove oscillations
from the system:
F
damp
i = −κui (4.30)
so that the total force acting on each particle is:
Fi =
n∑
j 6=i
F
rep
i,j + F
grav
i + F
damp
i (4.31)
The particle velocities are:
u
tDEM+∆tDEM
i = u
tDEM
i +
Fi
mi,DEM
∆tDEM (4.32)
and the new particle positions are:
x
tDEM+∆tDEM
i = x
tDEM
i + u
tDEM
i ∆tDEM (4.33)
The DEM particle mass mi,DEM is the actual mass of the particle normalised
by its mass at t=0. Once equilibrium is established, the next time step of mass
transfer occurs. The particle radii are then recalculated based on the new masses
they contain and the DEM code is called to ﬁnd the new particle positions.
4.2.6 Numerical integration and stability
To solve the mass balance equations, the Euler method is used which is forward
diﬀerence in time. Due to the nature of this method, the factors aﬀecting simulation
accuracy and stability are the underlying DEM code and the temporal discretisation.
For convergence and stability of the DEM code, the spring repulsion constant krep
can take any arbitrary value but the damping coeﬃcient κ and DEM time step
∆tDEM need to be chosen carefully (Malone and Xu, 2008); stable values are based
on the functions:
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Figure 4.13: Graphs showing the maximum force experienced by a particle to en-
sure DEM code is functioning properly (a). If the time step ∆tDEM is
too large (b) or the damping coeﬃcient κ is too small (c) the system
becomes unstable and if the convergence threshold is set too low, small
ﬂuctuations prevent the DEM code terminating (d).
∆tDEM = 0.005
(
min(mi,DEM)
krep
) 1
2
(4.34)
κ = 20
(
min(mi,DEM)
krep
) 1
2
(4.35)
For diagnostic purposes, a graph of the maximum particle force can be plotted
against successive iterations, which should decrease with every successive iteration.
If the DEM code is working well and is stable, the number of iterations required to
reach equilibrium will be small and if not, the force will increase or oscillate. Figure
4.13 shows an example of these graphs.
For the diﬀusion step, the limit of stability in 2D for the standard Cartesian grid
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(cf. Eq. 4.9) can be directly applied to the non-uniform 2D DEM grid to obtain:
∆t∗diff ≤
4max (Di,j)
min(d2i,j)
(4.36)
and this condition can also be directly applied to the non-uniform 2D DEM grid.
The maximum time step for dissolution is deﬁned as the time step that would be
required for a particle to lose half its mass assuming Afi = A
max
i and this is:
∆t∗diss = min
(
Vi
2Afi kdiss
)
(4.37)
However, as particles dissolve and shrink, it is necessary to ensure that over each
time step, the mass of polymer and water remaining in the particle is always positive.
It is also important to stop the DEM particle radius from becoming too small as
this signiﬁcantly slows the DEM part of the simulation. Therefore, a cut-oﬀ α is
deﬁned where if ri < αrt=0i then the particle is erased from the simulation and its
remaining mass is considered dissolved. If α = 0, ∆t∗diss ∼ 0 as t→ ∞ so a typical
value of α is 0.25. The time step ∆t required for numerical stability must be less
than both ∆t∗diff and ∆t
∗
diss .
4.3 Parametric optimisation
Optimisation in this context is the use of numerical methods to ﬁnd the value of one
or more parameters to meet speciﬁed criteria. In this work, optimisation was used
to minimise the diﬀerence between two data sets, such as adjusting the diﬀusion
coeﬃcient of a component so that a simulated drug release curve would closely
match that from experiment. The diﬀerence between two data sets (for example,
X1 and X2 can be described using the mean squared error MSE :
MSE =
1
n
n∑
i=1
(X1i −X2i )2 (4.38)
where ne is the number of elements in the data sets, in our case the number of
sampling points on a release curve. By minimising the MSE, the diﬀerence between
the data sets is minimised with respect to that parameter but there is no guarantee
that a change in a diﬀerent parameter than the one with respect to which the MSE
was minimised would reduce the MSE even further. For example, if drug release
is diﬀusion limited then changing the dissolution rate constant of the drug would
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have little impact on the drug release proﬁle. It is therefore important to conduct
parametric studies beforehand so that eﬀorts for optimisation can be targeted eﬀec-
tively. As the MSE is the dependent variable, it can be said that MSE = f(i) where
i is the input vector that through some function, is related to the MSE. If f(i) is
diﬀerentiatable then methods such as the steepest decent (Eq. 4.39) or Newton’s
method (Eq. 4.40) can be used to ﬁnd the minimum by specifying a starting value
i0, then performing successive iterations to obtain the minimum, where iterations
can be stopped based on some terminating condition such as max (ik+1 − ik) < b
where b is small.
ik+1 = ik − a∇f(ik) (4.39)
where a is a small value
ik+1 = ik −∇f(ik) [Hf(ik)]−1 (4.40)
The starting values are important, as if f(i) has more than one minimum, then even
small changes in the starting value can give diﬀerent values for the minimum. Figure
4.14 shows the steepest decent for a function containing two minima and two maxima
within the bounded area and how two slightly diﬀerent starting points cause diﬀerent
minima to be found. There is also the possibility that these methods could ﬁnish
on the saddle point although numerical approximations should cause the decent to
continue into one or the other minimum. Unfortunately both these methods require
the ﬁrst or second derivative at the starting and subsequent points to be known,
which means additional simulations need to be run as the surface is not known a-
priori. There may also be stability problems as if a is too large or the function is
such that Newton’s method fails. The initial guess also needs to be carefully chosen
to avoid problems although for formulation optimisation or parameter estimation it
would not be diﬃcult to choose sensible values. To avoid some of these problems,
two other methods were considered, one is a random sampling method and the
other is the Nealder-Mealds simplex method. The random sampling method takes a
set of input vectors Rk = {i1k, i2k, ...iqk} (where q is the number of vectors) randomly
distributed within a speciﬁed range around a central vector ic and this produces a set
of MSEs: Sk = {f(i1k), f(i2k), ...f(iqk)}. The coordinates which produced the lowest
MSE are then used as the central vector and the (k + 1)th iteration begins with
the same process, until the minimum is reached. This process is shown in Figure
4.15 and a further improvement would be to reduce the range around the minimum
to improve convergence. This simple method converges towards a minimum and
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Figure 4.14: Graph of function containing two minima f(x, y) = sin x sin y with
x ∈ [−3,+3], y ∈ [−3,+3]. The two optimisations (Descent A and B)
used the steepest descent method with slightly diﬀerent starting values,
demonstrating the possibility of ﬁnding one or the other minimum.
with suﬃcient computing power, the random samples can be computed in parallel
so that the entire parametric space could be mapped (i.e. the range is large), with
increasing resolution towards the minimum as the range is reduced.
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Figure 4.15: Graph of function containing two minima f(x, y) = sin x sin y with
convergence to one of the minima using the random seek method.
The method used for optimisation in this work was the Nealder-Mealds downhill
simplex algorithm. This algorithm, for an N dimensional parametric space, uses
(N + 1) points as initial guess and after calculating the MSEs, the Nth point with
the highest MSE is extruded through opposite side of the simplex and the new MSE
is computed. This process continues for the next highest point, resulting in the
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simplex moving over the surface towards a minimum. The particular algorithm also
uses additional steps to maintain stability and speed up convergence. When a new
point is chosen, if its MSE is lower than the previous lowest point, then it is tried
again but at twice the extrusion (as it may be possible to get closer to the minimum
in that direction) and if it worse, the extrusion is set to half (if the simplex has
over-stepped the minimum). If the half extrusion fails, the minimum is probably
within the bounds of the simplex so the whole simplex is shrunk by a half before the
next iteration begins. These stages ensure that if the initial simplex is too small, it
can grow to converge faster but still shrink when necessary for good convergence. A
modiﬁcation was made to the algorithm to take into account parameter boundaries,
so that if a new point is chosen which is beyond some limits (for example, the volume
faction of a component cannot be greater than unity), the values are clamped to
ensure they ﬁt within the parametric space. This modiﬁcation has a downside in
that the simplex can converge on a boundary and not ﬁnd the true minimum as if
all its points are equal in one or more dimensions as then optimisation would not
occur for those dimensions. This can be mitigated by performing the simplex in
sequential one dimensional stages rather than simultaneously but this requires more
iterations as only movement parallel to the axis is allowed at any given moment.
For a two dimensional surface, the simplex is a triangle, and can be envisioned to
tumble down the surface towards the local minimum and this is shown in Figure
4.16.
-3
-2
-1
 0
 1
 2
 3
-3-2-1 0 1 2 3
-1
 0
 1
Simplex
Simplex centre
-1
-0.8
-0.6
-0.4
-0.2
 0
 0.2
 0.4
 0.6
 0.8
 1
Figure 4.16: Graph of function containing two minima f(x, y) = sin x sin y with
convergence to one of the minima using the simplex method. The
simplex is drawn at selected iterations along the simplex centre’s path.
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Figure 4.17: Swelling simulation runtime as a function of DEM particle radius.
4.4 Software and hardware
The swelling and non-swelling models were written in Fortan 90/95 and run on
standard PC hardware (x86_64). Both models are roughly O(n2) in runtime with
respect to the number of voxels or DEM particles as further optimisation of the
internal algorithms such as the use of linked-lists was beyond the scope of this work.
However, some simple methods were used to decrease the runtime signiﬁcantly e.g.
decreasing the cache misses through mindful loop structuring or using the fact that
when when calculating the mass ﬂux or force between DEM particles i and j, the ﬂux
or force from j to i is the same in the opposite direction. The scope for optimisation
is far greater for the swelling model as DEM is naturally computationally intensive.
If the grid size used for the non-swelling model (300× 300) was used as a basis for
the DEM particle radius, each particle would need to be about 1.5 × 10−5m which
would increase the runtime dramatically as can be inferred from Figure 4.17.
Using OpenMP it is possible for the code to make use of multiple CPUs within a
symmetric multiprocessor system (SMP) and whilst an ideal speed-up would scale
linearly with increasing number of processors, overheads such as thread synchroni-
sation points (barriers) begin to have more inﬂuence as the workload is divided into
smaller units per processor. When conducting parametric studies, multiple instances
of the model can be run depending on the number of processors within the machine,
removing any overheads associated with parallelisation but possibly increasing the
runtime of the entire study depending on the order in which each simulation is run.
Ideally all processors would be in use 100% of the time, but as some simulations
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take longer than others, there would inevitably be a point towards the end when
not all processors are in use.
To run a parametric study, the variables in question are assigned to “levels” where
each subsequent level is branched from the previous. For example, if level 1 contained
the variables [a, b, c] and level 2 contained the variables [1, 2, 3] then 9 simulations
would be run, each simulation using one of the input vectors from the expanded
set [(a, 1), (a, 2), (a, 3), (b, 1), (b, 2), (b, 3), (c, 1), (c, 2), (c, 3)]. As the model reads its
input parameters from a ﬁle (settings), the input vectors are simply written directly
to the correct location in the ﬁle, replacing the default values. Multiple settings are
generated using a recursive shell script before any simulations are run so that the
ﬁles can be inspected or single instances run to give an idea of runtime. It may be
desirable to use more than one computer to run a parametric study, in which case
diﬀerent settings ﬁles can be copied to diﬀerent machines (nodes). The allocation is
manual based on the estimated computational power of each node. To coordinate
and monitor the progress of each simulation, a Perl script on each node is used which
1) checks the number of simulations running against the number of local processors
and starts simulations until all processors are occupied and 2) copies information
about the progress of the current and ﬁnished simulations to a web server so that
each node can be monitored (Figure 4.18). For automated work allocation across
multiple nodes, cluster management software such as TORQUE and Maui could be
used.
Figure 4.18: Snapshot of node monitoring web page.
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Generating visual output from the model such as release curves was carried
out using gnuplot (http://www.gnuplot.info/) and for the non-swelling results,
OpenDX (http://www.opendx.org/) was used to show the concentration gradi-
ents across the tablet. For the swelling model, it was desirable to view the the
particles, whose colour was representative of some quantity such as mass fraction of
water, along with the interconnecting lines (to show links between neighbours), mass
transfer areas (represented by lines as there is no change in the z-direction) and edge
particles (which particles were considered to be on the edge according to the edge
detection algorithm). Gnuplot version 4.2 patchlevel 6 as installed by default on
Ubuntu 10.04 could not plot circles of a speciﬁed radius and colour, whereas version
4.5 and upwards did. At the time of this work, the circles generated by gnuplot
were of poor quality, using an excessive number of points to deﬁne the edge of the
circle (a circle can be approximated using a 4 point Bézier spline) so a Perl script
was used to generate postscript ﬁles showing this information. Using this method
also resulted in a ten-fold reduction in ﬁle size when plotting the same data using
the Perl script compared to gnuplot.
5 Model Validation
This chapter tests the non-swelling and swelling models against analytical or exact
numerical solutions. The non-swelling model validation (Section 5.1) is published
in (Kimber et al., 2011b), the validation of the DEM method for diﬀusion over
static grids (Section 5.2) is published in (Kimber et al., 2011a) and the validation
of diﬀusion over dynamic grids (Section 5.3) has been published in (Kimber et al.,
2012)
5.1 Diffusion over Cartesian grid
In order to verify the diﬀusion part of the non-swelling model (cf. Eq. 4.2 in Section
4.1.2), a single component tablet is dissolved, where in the ﬁrst time step, all solid
material dissolves (k is large and water ingress is instantaneous). The dissolved
material diﬀuses over subsequent time steps towards the domain boundary, where
concentration is set to zero. The solutions for this system assuming an inﬁnite
domain size are well known (Crank, 1975) and given by the following equation:
c =
ct=0
2
{
erf
hs − x
2
√
Dt
+ erf
hs + x
2
√
Dt
}
(5.1)
For the simulation, D, c(t = 0) and hs are set to 1 with a domain size of 10. As can
be seen in Figure 5.1, at short times where the material has not yet diﬀused to the
edge of the computational domain, the concentration proﬁles from the analytical
solution and simulations match exactly (Figure 5.1).
5.2 Diffusion over static DEM grid
The swelling model uses a novel tessellation algorithm to calculate the mass transfer
areas between DEM particles and it is necessary to test the validity of this algorithm
for diﬀerent particle size distributions and conﬁgurations. For this study, the number
of particles is set to 5000 and each particle is given an initial random position
xi = (x, y) within a square domain of side length l. Volume change of DEM particles
89
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Figure 5.1: Analytical solution and simulation concentration proﬁles where numbers
on the curves are values of t.
or dissolution is not considered in this section, only the diﬀusion of material between
DEM elements so the mass balance between DEM elements is given by:
Vi
dci
dt
=
∑
j 6=i
Ai,j
δi,j
D(ci − cj) ∀j : δi,j − (ri + rj) ≤ λmin(ri, rj) (5.2)
where λ = 1/3, D is the diﬀusivity of the component, δi,j is the Euclidean distance
between particle centres of i and j, Ai,j is the mass transfer area between i and j
given by Equation 4.19 and Vi is the eﬀective volume of particle i. The i-th and j-th
particles are considered neighbours according to the condition in Equation 5.2. The
value of λ determines how far apart particle i and j can be for them to be considered
neighbours based on the radius of the smaller particle so that mass transfer can occur
between particles which are not quite in contact but not between particles which are
too far apart. In this work, λ = 1/3 was found to be a reasonable value to satisfy
the aforementioned criteria. The volume of the DEM particles Vi is the same as
described in section 4.2.2.
5.2.1 DEM particle packing formation
The particle size distribution is given by setting a mean particle radius r¯ and a
standard deviation σr and by using these parameters, it is possible to construct a
Gaussian curve to give a particle size distribution:
f(ri) =
1√
2πσr2
e
− (ri−r¯)
2
2σr2 (5.3)
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Figure 5.2: Graph showing Gaussian distribution and various random coordinates
either accepted (if they are below the Gaussian distribution curve and
within the standard deviation speciﬁed) or rejected if outside either of
these regions.
Numerically, the random number generator produces a uniform distribution, so
rejection sampling was used to obtain particle sizes that conform to a Gaussian
distribution with a standard deviation of σr. Figure 5.3 demonstrates this graph-
ically, where both the x and y coordinates are chosen at random, but only those
points which fall below the Gaussian distribution curve and within ±1σr of r¯ are ac-
cepted. In the actual numerical implementation, the random coordinates are chosen
within a box bounding the minimum and maximum allowed radius, and the height
of the Gaussian distribution at r¯ as this would decrease the number of rejected
particles. The particle size distribution parameters used for these simulations were
r = 8×10−3l, σr = η.r, where η = 0, 0.2, 0.4, 0.6, 0.8. The particles are then subject
to a small gravitational force at the centre of the domain to bring them into con-
tact without overlapping. A regular (hexagonally) packed structure was also tested
without using the gravitational force by placing the particles row by row instead
of randomly. Figure 5.3 shows the eﬀect of changing η on the packing structure.
When η = 0, the packing is still irregular as the gravitational attractive force in this
instance was relatively weak, so as to enable clusters of regularly packed particles
with some regions of discontinuity. Five random seeds were used to generate diﬀer-
ent packing structures with the same particle size distribution for each η in order to
obtain standard deviations for each result.
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5.2.2 Initial and boundary conditions for uni-directional
diffusion
Once the random particle packing has been formed, the mass transfer problem de-
ﬁned by Equation 5.2 was solved for a subset Ω of DEM particles deﬁned by:
Ω = {i : (ymin < yi < ymax) ∧ (xmin < xi < xmax)} (5.4)
where in our case the domain boundaries are positioned at xmin = 0.25l, xmax =
0.75l, ymin = 0.00625l and ymax = 0.9375l. Let us also deﬁne the following sets for
the boundary conditions:
B1 = {i : (yi ≥ ymax) ∧ (xmin < xi < xmax)} (5.5a)
B2 = {i : (yi ≤ ymin) ∧ (xmin < xi < xmax)} (5.5b)
The initial conditions were ci(t = 0) = 0 and the following boundary conditions
were applied:
ci =

c0 if i ∈ B10 if i ∈ B2 (5.6)
where in our case c0 = 1 and the diﬀusion coeﬃcient D = 1. The boundary condi-
tions are also shown in Figure 5.3.
5.2.3 1D reference solution
In order to validate the mass transfer solutions obtained on the DEM grid, a reference
solution is necessary. This solution was obtained by solving a 1D mass transfer
problem :
∂c
∂t
= D
∂2c
∂y2
(5.7)
by a second order ﬁnite diﬀerence (FD) approximation with a spatial resolution
ﬁner than that of the DEM mesh (1/10th of the smallest particle radius). Although
this solution was obtained numerically, it can be regarded as an “exact” solution for
validation purposes.
The initial and boundary conditions are the same as those used for the DEM
simulation, i.e. c(ymin < y < ymax, t = 0) = 0, c(y ≥ ymax, t) = c0 and c(y ≤
5.2. DIFFUSION OVER STATIC DEM GRID 94
 0
 0.2
 0.4
 0.6
 0.8
 1
 0  0.2  0.4  0.6  0.8  1
c/
c 0
 
[-]
y/l [-]
02510t → ∞
Regular packing
Finite Difference
Figure 5.4: Concentration proﬁles at diﬀerent times for the transient case where
hexagonally packed mono-sized particles are used.
ymin, t) = 0. Both transient and steady state mass ﬂuxes were analysed. For the
steady-state case, the diﬀerence between the mass ﬂuxes at the top and bottom of
the diﬀusion domain were compared. For the transient cases (non-steady-state), the
mean squared error
MSE =
1
n
n∑
i=1
(cDEMi − cFD(y = (yi))2 (5.8)
is used to characterise the diﬀerence between the FD and DEM concentration
proﬁles, which is calculated by sorting all particles within the simulation domain in
order of their y position, plotting the particle concentrations against position and
comparing this to the FD solution as shown in Figure 5.4. As the circumradius
of the equivalent hexagon is used to determine each DEM particle’s volume, it is
expected that regular (i.e. hexagonal) packing would give the smallest error as the
mesh becomes an exact Finite Volume system.
5.2.4 Determination of the effective diffusion coefficient
For the unstructured grids, the distance over which mass diﬀuses is slightly longer
than the regular grid with the same boundary conditions. It was proposed that
diﬀusion across the unstructured grid is analogous to diﬀusion through porous ma-
terial and thus the diﬀusion coeﬃcient could be replaced by an eﬀective diﬀusion
coeﬃcient, taking into account the grid’s “porosity” (conducting phase volume frac-
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Table 5.1: Table of average volume fraction (φ) and tortuosity (τ) values for diﬀerent
η. The means and standard deviations based on 5 random seeds are
shown.
η 0 0.2 0.4 0.6 0.8
φ 0.804 ± 0.006 0.844 ± 0.002 0.889 ± 0.002 0.914 ± 0.002 0.928 ± 0.003
τ 1.037 ± 0.008 1.103 ± 0.006 1.107 ± 0.007 1.110 ± 0.005 1.102 ± 0.009
tion) and tortuosity. The eﬀective diﬀusion coeﬃcient can be given as a function of
porosity φ and tortuosity τ :
Deff = Dφ/τ (5.9)
However, the values of volume fraction and tortuosity are unknown and depend on
the particular unstructured grid. The volume fraction φ can be calculated based on
the volume of the DEM particles (equivalent hexagons) against the volume enclosed
by the deﬁned boundary conditions V = (ymax − ymin)(xmax − xmin)dz :
φ =
∑
i∈Ω
Vi/V (5.10)
The tortuosity can be found in a diﬀerent way, as after a long time, the system
reaches steady-state and the concentration proﬁle in the y direction becomes a
straight diagonal line. For these tests, steady state was deﬁned as the point when the
mass ﬂuxes of material leaving the upper boundary and entering the lower boundary
were equal to within 1 × 10−8 of each other. In an ideal case, the mass ﬂux across
the unstructured grid should be the same as the ﬁnite diﬀerence solution and if it is
not then the eﬀective diﬀusion coeﬃcients must be diﬀerent, and since D and φ are
known and all else being equal, the tortuosity can be found as a ratio of the mass
ﬂuxes:
m˙DEM =
∑
i∈Ω
∑
j∈B1
Ai,j
δi,j
D(ci − cj) (5.11a)
m˙FD = (xmax − xmin)dzD (c0 − 0)
(ymax − ymin) (5.11b)
∴ τ = φ
m˙FD
m˙DEM
(5.11c)
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Table 5.1 shows how the average volume fraction and tortuosity values change
with respect to the particle size distribution factor η. The volume fraction of the
system increases with increasing η due to the better packing oﬀered by the diﬀerent
sized particles. This can also be seen in Figure 5.3 where the randomly distributed
mono-sized particles pack relatively poorly compared to the other cases. In this
case, an adjustment of the underlying DEM code would be necessary to improve
the packing. It is also interesting to see that the tortuosity of the system increases
with increasing η; again Figure 5.3 shows that the path between the boundaries
is straighter for the monosized particles compared to the other cases, and this is
quantiﬁed by increasing tortuosity. With this information, it should be possible to
adjust the eﬀective diﬀusion coeﬃcient so as to correct for imperfections in the grid.
These correction methods are detailed in the next section.
5.2.5 1D diffusion validation results
The concentration proﬁles on the DEM grid should agree with the accurate Finite
Diﬀerence solutions at all times (not just steady state) and Figure 5.4 shows the
transient cases for regularly packed DEM particles, where the concentration proﬁles
at diﬀerent times match exactly. However, irregular DEM packing results in in-
creased porosity and tortuosity slowing down the diﬀusion. Two correction methods
were tested to see if a lower mean squared error could be obtained. The correction
methods involved multiplying the base diﬀusivity D by a factor so as to correct for
the slow-down introduced by the irregular packing. This correction factor could be
equal for all particles (global compensation) or calculated for each pair of particles as
they transfer mass between each other (local compensation). In all tests, concentra-
tion proﬁles are output every second up to a ﬁnal time of 10 seconds and these are
compared against the equivalent concentration proﬁles from the Finite Diﬀerence
solution.
In the best case, where particles are hexagonally packed, there would still be
small diﬀerences between the ﬁnite diﬀerence solution and the unstructured grid.
As mentioned previously in Section 5.2.1, r = 8× 10−3l and by changing this value,
it is possible to see the eﬀect of DEM particle size without any porosity or tortuosity.
Table 5.2 shows the mean squared errors of concentration proﬁles at progressive time
steps.
In all cases, the magnitude of the mean squared error is very small and the se-
lection of r = 8 × 10−3l is a good compromise between accuracy and simulation
runtime.
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Table 5.2: Table of mean squared errors at diﬀerent times between the ﬁnite diﬀer-
ence and unstructured grid concentration proﬁles for hexagonally packed
DEM particles.
t [s]
r
5× 10−3l 8× 10−3l 16 × 10−3l 32× 10−3l
0 4.11 × 10−6 9.96 × 10−6 2.59 × 10−5 3.63 × 10−5
10 2.11 × 10−6 5.78 × 10−6 1.93 × 10−5 6.99 × 10−5
20 6.20 × 10−7 1.73 × 10−6 6.21 × 10−6 3.07 × 10−5
40 4.21 × 10−8 8.21 × 10−8 6.59 × 10−7 1.67 × 10−6
60 2.45 × 10−8 3.71 × 10−8 4.30 × 10−7 1.43 × 10−6
5.2.5.1 No compensation
Initially the eﬀective diﬀusion coeﬃcient was not adjusted for any porosity or tortu-
osity eﬀects so that the magnitude of the mean-squared error between the FD and
DEM solutions could be evaluated. These tests were allowed to run for more than
10 seconds in order to show the diﬀerences between the ﬁnal concentration proﬁles
and the FD solution. The magnitude of the mean squared error from the mono-sized
regular packing is around 1×10−5. The mean squared errors for the random particle
packings are shown in Figure 5.5.
From Figure 5.5, it can be seen that with no correction of the diﬀusion coeﬃcient,
the error reaches about 0.4× 10−3 for t > 0 and falls to a value around 0.05× 10−3.
Over time, all cases tend towards a set value and the reason this is not exactly zero
is due to the spatial positioning of the discrete elements and sight diﬀerences in the
boundary conditions of the FD and DEM simulations.
5.2.5.2 Global porosity and tortuosity compensation
For these tests, the values for porosity and tortuosity obtained from the steady-state
experiment have been used to correct the diﬀusion coeﬃcient for all particles (i.e.
their eﬀective diﬀusion coeﬃcients are the same). This has the eﬀect of speeding
up the diﬀusion, counteracting the eﬀect of porosity and tortuosity within the un-
structured grid. The results of this are shown in Figure 5.6. For polydispersed
randomly packed particles, the correction improves as the particle size distribution
increases but performs far worse than no correction for the mono-sized particles.
For this particular case (η = 0), the compensation results in a worse error because
the correction applied to the diﬀusion coeﬃcient is too much. In some regions the
packing of mono-sized particles is poor but this is not the case for the whole domain
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Figure 5.5: Graph showing diﬀerences and variation in the mean squared error be-
tween the standard deviation factors at diﬀerent times where no com-
pensation for porosity and tortuosity is applied.
(Figure 5.3) and increasing the diﬀusion coeﬃcient globally to compensate for the
few areas of poor packing increases the mass ﬂux for all elements resulting in faster
mass transfer than is necessary. At higher η, the packing becomes more eﬃcient and
tortuosity becomes the dominating factor. As tortuosity is deﬁned for the entire sys-
tem, it can be applied globally for all particles. As a result, the mean squared error
for higher η is almost half that of the case with no compensation.
5.2.5.3 Local porosity compensation
Tortuosity can only be calculated once steady-state mass ﬂux is achieved on the
unstructured grid. However, during simulations of swelling polymers which is the
ultimate aim of this work, this information will not be available. A method that
would work without any a priori knowledge of the steady state solution would be to
calculate the local volume fraction (i.e. the volume occupied by a particle and its
neighbours) against the volume of the space the particle and its neighbours occupy,
giving a local porosity. For mass transfer between pairs of particles, the diﬀusion
coeﬃcient D is divided by the average of the local porosities of the particles, increas-
ing the eﬀective diﬀusivity and counteracting the eﬀect of porosity. To calculate the
local porosity for each particle the following proceedure is used:
• For a single DEM particle i, convert it and its neighbours into hexagons and
store the x,y coordinates of all the vertices.
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• Sum volume of DEM particle i and the neighbours, store as the DEM volume
Vsum
• Construct convex hull of all the vertices using the Graham scan algorithm
• Find the volume of the convex hull Vhull by dividing the hull into triangular
sections and calculating half the determinant of the coordinates within each
triangle, multiplied by the height dz
• Deﬁne local porosity εlocal = VsumVhull
Figure 5.7 shows a particle and its neighbours, along with the convex hull and
DEM particle volumes (equivalent hexagons). During mass transfer between two
particles, the diﬀusion coeﬃcient is divided by an average local volume fraction of
the particles and the resulting mean squared errors when using this compensation
method are shown in Figure 5.8. In this case, the beneﬁt is obvious, reducing the
mean squared error by a factor of 2 in most cases bar the mono-sized randomly dis-
persed particles. However, this method is computationally intensive since a convex
hull would need to be generated for every particle, taking into account all of the
particle’s neighbours.
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Figure 5.6: Graph showing diﬀerences and variation in the mean squared error be-
tween the standard deviation factors at diﬀerent times where global com-
pensation for porosity and tortuosity is applied, i.e. the diﬀusivity co-
eﬃcient is multiplied by the tortuosity and divided by porosity whose
values were obtained from the steady state case.
5.2.5.4 1D diffusion conclusions
Although it can be seen that both compensation methods reduce the MSE compared
to no compensation, the actual diﬀerence between the two (and no compensation) is
small; this can be seen by comparing the concentration proﬁles of the compensation
methods and the FD solution. Figure 5.9a shows that even for the worst case
of mono-sized randomly packed particles, the magnitude of the error between the
curves is relatively small and the compensation methods make do not always make
a signiﬁcant improvement. Where compensation methods were successful, as in the
case of η = 0.8 shown in Figure 5.9b, the gain in accuracy is evident, however
the increased complexity and run time of the code would be signiﬁcantly worsened
should the correction methods be applied during coupled simulations of diﬀusion and
swelling. As the sources of inaccuracy are the packing algorithm and the particle
size distribution, improvements in the former would mitigate a large proportion
of the error (i.e. using more gravitational force or inter-particle attraction) and
reducing the latter is more complex though possible through the use of particle
division or agglomeration should a particle’s radius be outside an accepted range
(i.e. large particles are divided into smaller ones, and groups of small particles can
be agglomerated into a single unit).
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Figure 5.7: Neighbours of particle i considered (a), the convex hull formed around
the particle i and its neighbours (b) which is compared to the equivalent
hexagons of those particles (c).
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Figure 5.8: Graph showing diﬀerences and variation between the standard devia-
tion factors for diﬀerent times, correcting the diﬀusion coeﬃcient using
local porosity calculated using the convex hull of each particle and its
neighbours.
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5.2.6 2D diffusion
As the grid formed by DEM particles is two-dimensional in nature, it is important
to also validate it against a 2D system. In these tests, the particles are arranged in
a circular domain of radius r0, and additional particles beyond r0 form a boundary
condition. Assuming (0,0) as the centre of the domain, the initial and boundary
conditions can be expressed formally in radial coordinates as: c(r > r0, t) = c0,
c(0 < r < r0, t = 0) = 0. Similar to the 1D case, a numerically exact ﬁnite
diﬀerence scheme comprising of concentric rings is used to solve the same mass
transfer problem, so that the mean squared error between concentration proﬁles over
time can be compared. Additionally, the total mass of material diﬀusing into the
system can be plotted over time and compared to the ﬁnite diﬀerence solution. The
particle size distributions used are the same as the 1D case and regular hexagonal
packing case is also compared. Similar to Figure 5.3, Figure 5.10 shows the initial
conditions and conditions at 2.5 seconds for regular packing and one of the random
particle distributions (η = 0.8).
5.2.6.1 2D diffusion results
Figure 5.11 shows the mean squared errors between the radial concentration proﬁles
from the unstructured grid and the ﬁnite diﬀerence solutions over time and Figure
5.12 shows some of the radial concentration proﬁles for a polydisperse system where
η = 0.8. Unlike the 1D case where the concentration proﬁle approaches a straight
line, the 2D case has material diﬀusing into the domain and increasing in concen-
tration until equilibrium is established with the boundary which is a more complex
transient case. In the 2D studies, the gravitational force was set slightly higher
so that when η = 0, the monodisperse particles arrange themselves into a regular
packed structure. This particular case, η = 0, shows the eﬀect of slight diﬀerences
in the initial conditions between the DEM and numerical ﬁnite diﬀerence solutions
and thus the eﬀect of polydispersity (other values of η) on the mean squared error
can again be directly compared to errors introduced because of the initial condition
diﬀerences. The magnitude of error is higher in the 2D case than in the 1D case
as sub-optimal tessellation becomes more important towards the centre where there
are fewer particles but as in the 1D cases, the greater polydispersity can reduce the
error.
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Figure 5.9: Eﬀect of diﬀerent compensation methods on the concentration proﬁle for
mono-sized randomly packed particles (a) and η = 0.8 randomly packed
particles (b).
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Figure 5.10: Initial conditions and concentration proﬁles at 2.5 s for regular packing
(left) and packing with η = 0.8 (right) for a 2D system.
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Figure 5.11: Graph showing diﬀerences and variation in the mean squared error be-
tween the standard deviation factors at diﬀerent times for concentration
proﬁles in the 2D conﬁguration.
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Figure 5.12: Comparison of radial concentration proﬁles between DEM and numer-
ical solution, for a single random seed where η = 0.8.
5.3 Diffusion over dynamic DEM grid
5.3.1 2D reference solution
In order to validate the DEM model, a reference solution is necessary. For dif-
fusion with a non-linear concentration-dependent diﬀusion coeﬃcient coupled with
swelling and dissolution, analytical solutions can no-longer be obtained. An “exact
numerical” solution based on a diﬀerent method than DEM then remains as the
next best option for carrying out validation studies. As the tablet is cylindrical, the
concentration of water in the tablet cw is a function of radial coordinate and time
only:
∂cw
∂t
=
1
r
∂
∂r
(
rDw
∂cw
∂r
)
(5.12)
The polymer dissolves from the edge of the tablet:
dmp
dt
= −kdiss2πrtdz (cp − cpbulk) (5.13)
if φ(r = rE) ≥ φd (5.14)
where rE is the erosion radius of the tablet. The initial conditions for both compo-
nents are:
cw(r, t = 0) = 0 (5.15a)
cp(r, t = 0) = ρp (5.15b)
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so that the tablet is initially dry and the tablet contains only polymer. The boundary
conditions are:
∂cw
∂r
∣∣∣
(r=0,t)
= 0 (5.16a)
−Dw ∂c
w
∂r
∣∣∣
(r=rE)
= kw(φ
∗ρw − cw) (5.16b)
As mentioned in Section 5.2.6 an accurate numerical solution can be found using
using a ﬁnite diﬀerence scheme (Figure 5.13), where the tablet is discretised into
concentric cylinders, and the mass balanced solved over each ring. The solution can
be adjusted to take into account swelling or non-swelling behaviour (Figure 5.14).
It should be noted that in the non-swelling case, volume is not conserved (i.e. the
ingressing water does not increase the volume of the rings), however this behaviour
can be mirrored by the DEM code so as to test diﬀusion only rather than diﬀusion
and swelling (Section 5.2.6).
r
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n
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Figure 5.13: Tablet discretisation for numerical Finite Diﬀerence code.
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Figure 5.14: Example of non-swelling and swelling tablet (without dissolution) using
the Finite Diﬀerence code.
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5.3.2 Swelling
The quantities of interest with respect to model validation are the concentration pro-
ﬁles of water and polymer plotted radially at diﬀerent times and the uptake/release
of water/polymer over time. To validate the mass transfer of water without polymer
dissolution, φd > φ∗. Figure 5.15 shows the spatial arrangement of DEM particles
over time for this case and several spatial discretisations (i.e., initial sizes of the
DEM particles). Table 5.3 then shows a summary of diﬀerent DEM particle radii
on the solution accuracy. When calculating the mean squared errors, the tablet
radius over time is normalised with respect to the starting radius. Smaller particles
produce a lower mean squared error but for very small DEM particles the reduction
in error is less signiﬁcant and would not be worth the increase in computational
time. The error also tends towards a minimum value rather than zero, indicating
improvements elsewhere would have a greater impact on further reductions in the
numerical error. It was determined that for accurate yet reasonably fast simulations,
the initial DEM particle radius ri should around 6% the tablet radius rt. Figure
5.16 shows a comparison of the radial concentration proﬁles of water from the DEM
simulation and reference solution.
Table 5.3: Mean squared errors for normalised tablet radius over time between DEM
and numerical solutions for diﬀerent DEM particle radius, swelling-only
case.
Number of particles DEM radius [m] Mean squared error [%]
12 40× 10−5 37.5
49 20× 10−5 4.49
203 10× 10−5 0.867
1274 4× 10−5 0.751
5099 2× 10−5 0.289
5.3.3 Swelling and dissolution
When φd < φ∗, the polymer can dissolve once the disentanglement threshold is
reached. The dissolution rate is determined by kdiss . Again, a similar set-up was
used, where the expansion and dissolution of the tablet can be compared to that of
the numerical solution for diﬀerent particle radii. These results are shown in Table
5.4 and as before, the error decreases with smaller DEM particles. Figure 5.17 shows
the diﬀerence between polymer release curves obtained by the DEM simulation and
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Figure 5.15: Images showing polymer concentration over time for diﬀerent DEM
particle radii. Parameters are given in Table 7.1 except β = 1, Dmin =
Dmax = 2 × 10−10, kdiss = 4 × 10−8, φd = 0.8, φ∗ = 0.95. The graph
shows tablet radius over time when ri = 4 × 10−5m and the vertical
dotted lines correspond to the times in the above images.
a reference solution for initial DEM particle size 4×10−5 m. The model can now be
considered validated from the numerical accuracy point of view. The size of a DEM
particle giving a reasonable compromise between speed and accuracy is 5 × 10−5,
which will be used in subsequent simulations, parametric sensitivity studies and
validation against experimental data.
Table 5.4: Mean squared errors for normalised tablet radius over time between DEM
and numerical solutions for diﬀerent DEM particle radius where both
swelling and dissolution occur simultaneously.
Number of particles DEM radius [m] Mean squared error [%]
12 40× 10−5 16.4
49 20× 10−5 9.80
203 10× 10−5 2.86
1274 4× 10−5 1.52
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Figure 5.16: Radial concentration proﬁles of water for DEM and numerical simula-
tions for the swelling case, plotted every 5000 seconds and ri = 2×10−5
m.
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Figure 5.17: Polymer release curve for DEM and numerical simulations where ri =
4× 10−5 m.
6 Non-swelling Tablet Simulation
and Experimental Results
This chapter contains the parametric studies and experimental optimisation results
for the non-swelling model, which is also published in Kimber et al. (2011b).
6.1 Numerical parametric studies
The following numerical studies were conducted to demonstrate some of the poten-
tial uses of the model and how the data obtained can be used to help with excipient
selection or powder processing parameters. The simulated tablets contain two com-
ponents, referred to as component A and component B. The role of A and B as
excipient or drug is not explicitly deﬁned, as the parametric studies consider the re-
lease of both components and how they aﬀect each other to be of interest. Table 6.1
shows the parameter values used in the subsequent studies. For the two component
system, there are two saturated concentration values but both components have the
same density, diﬀusivity and dissolution rate constant in order to emphasise the
eﬀect of component solubility on the release of A and B rather than a combination
of diﬀerent values. The dissolution rate constant is set to a high value to ensure the
process is diﬀusion limited.
Initially, tablets containing only A or B were simulated so that comparisons can
be made relative to the pure component release times. Table 6.2 shows the release
times for pure component tablets. It is also useful to compare component i release
times (t90,i) resulting from parameter changes with the value of the pure component.
In these cases, relative release times are shown, denoted by t∗90,i. For the ideal case
where both components can dissolve independently of each other (i.e. a completely
homogeneous tablet), the release time of a component is equal to the pure component
release time multiplied by its volume fraction, so a tablet containing only 50% v/v
component A would have a t90 half that of the pure component A tablet. This ideal
case is linear and is shown graphically where appropriate.
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Table 6.1: Values of ﬁxed simulation parameters and default values of variable pa-
rameters for components A and B.
Parameter Unit A B
Diffusion coefficient D0 m
2s−1 5× 10−10 5× 10−10
Dissolution rate constant k s−1 1× 1011 1× 1011
Saturated concentration kgm−3 20 200
Density ρ kgm−3 1500 1500
Diffusivity exponent α - 1 1
Domain size [mm] 10
Domain height [mm] 5
Discretisation [x,y,z] 300×300×1
Tablet radius [mm] 3
Table 6.2: Integral release times for tablets containing only component A or B.
Integral time [hr] Component A Component B
t10 9.08 1.42
t50 48.6 5.83
t90 103 12.3
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Table 6.3: Average release time t90 [hr] of Components A and B. In both cases, Lc
refers to component A.
Lc
φA
0.2 0.5 0.8
66 µm 22.6 (± 0.3) 53.0 (± 0.7) 83.3 (± 0.5)
133 µm 23.7 (± 0.7) 53.3 (± 1.2) 83.5 (± 0.9)
200 µm 24.8 (± 1.3) 54.1 (± 1.7) 83.8 (± 1.3)
Lc
φB
0.8 0.5 0.2
66 µm 11.3 (± 0.1) 24.0 (± 7.9) 75.3 (± 3.6)
133 µm 11.7 (± 0.4) 18.3 (± 3.5) 65.3 (± 7.1)
200 µm 11.7 (± 0.3) 14.2 (± 1.7) 54.6 (± 16.0)
6.1.1 Effect of particle size and size distribution
This parametric study was aimed at assessing the eﬀect of particle size on the com-
ponent dissolution rates. An overview is shown in Figure 6.1. Three tablet com-
positions were used, namely 20 %, 50 % and 80 % component A volume fraction.
For each of these, three correlation lengths are chosen (which control the size of the
convolution kernel for Gaussian smoothing, given by Equation 4.1). The correlation
lengths chosen correspond to particle sizes typical of those used in pharmaceutical
tablets (Rohrs et al., 2006; Millán et al., 1998). Correlation length and particle size
are synonymous in this section, where the correlation length controls the size of con-
tiguous regions of the n-1th components for n components. The Gaussian smoothing
is applied twice for all cases. Lastly, 5 random seeds are chosen. The random seed
changes the initial random matrix and hence the distribution of particles within the
ﬁnal tablet. The total number of simulations is 45.
Volume fraction of component A 20% 50% 80%
Correlation length [µm] 66 133 200
Random seed 1261 2345 3678 6747 9251
Figure 6.1: Structure of the parametric study of the eﬀect of tablet composition and
microstructure.
The results are summarised in Table 6.3 and Figures 6.2 and 6.3. Table 6.3 shows
the integral release time t90 for each component as a function of tablet composition
and the correlation length of component A. Each value is the mean based on ﬁve
random tablet realizations and the standard deviation is also given. The dimension-
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less relative release time plotted in Figs. 6.2 and 6.3 is deﬁned as the actual release
time for a given tablet composition divided by the time it would take to dissolve the
component from a pure tablet of the same radius and height, containing only that
component. It is thus a measure of the eﬀect the presence of the second component
had on the release time of the original component.
From Figure 6.2, particle size and component fraction have little eﬀect on the
values of t90 of component A, which is the less soluble component. There is a small
deviation from ideality which would be due to the increasing particle size, hence
the lines for diﬀerent particle sizes are all above the ideal. The larger particle size
(correlation length 200 µm) produces slightly slower dissolution than the smaller
particles due to surface area eﬀects. This eﬀect diminishes as the fraction of compo-
nent A increases. Since component A is ten times less soluble than B, component B
would not aﬀect the release rate of A and thus as observed, component A’s release
is mostly aﬀected by the particle size parameter rather than the presence of B.
For component B, Figure 6.3 shows large deviations from ideal behaviour as com-
ponent A’s volume fraction increases. This can be explained by the trapping eﬀect
of component A which limits the release rate of B. This rate limiting eﬀect dimin-
ishes as particle size increases as for large particles, once an area is exposed to the
liquid phase, that particle can dissolve out freely. For the small particles and high
volume fractions of A (80%), component B’s release time would approach that of A.
For lower volume fractions (20% and 50%) of component A, interparticle contact is
increasingly likely for component B and the inﬂuence of trapping by component A
becomes diminished (cf. Figure 4.2). This can be related to the percolation thresh-
old, where a single continuous porous structure of component B becomes more likely
at higher loadings. The volume fraction at which percolation would occur for square
objects aligned parallel is shown to be around 0.66 (Baker et al., 2002). The frac-
tion at which component A becomes insigniﬁcant is near this value. Caraballo et al.
(1993) found during percolation studies of tablets that at high drug loadings (60-
80% w/w), disintegration occurred. From Tables 6.2 and 6.3 and Figure 6.3, it can
also be seen that for 80% v/v component B, the t90 value is lower than the pure
component value, even though component A should slow the dissolution of B. This
demonstrates that the presence of component A actually enhances the dissolution
time of B compared to its pure component value (11.7s vs 12.3s). Simulated granule
dissolution studies (Ansari and Štěpánek, 2006) also show the presence of this local
minimum for similar cases.
From the Quality by Design (QbD, cf. Section 1) point of view, the variability of
component release times and the dependent variables are of particular importance.
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The standard deviations for both component release times are shown in brackets in
Table 6.3 and as error bars in Figures 6.2 and 6.3. The variation in release times for
component A are insigniﬁcant, being below 4% of the mean release time for all vol-
ume fractions and particle sizes. For component B, the variability generally increases
as particle size and volume fraction of A increase. It is interesting to note that for
50% v/v of component B, variability is highest for the smallest particles whereas for
lower volume fractions of B (20%), the variability is greatest for the large particles.
For the 20% volume fraction of B, the small particles have the longest release time
but the least variation as they are more evenly dispersed within component A and
small variations in their placement do not greatly aﬀect the overall release time.
Conversely, the large particles (correlation length 200 µm) have the largest variation
at this volume fraction as their dissolution is highly position dependent.
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Figure 6.2: Eﬀect of particle size (expressed by the correlation length) and volume
fraction on t∗90,A.
Whilst the term API and excipient have not been assigned to either component A
or B, the role of the excipient is often to slow the dissolution of the drug and therefore
the excipient could be assigned to component A (low solubility), with the API being
component B (high solubility). If this were the case, the results show that it is very
important for quality control purposes to control aggregate size with respect to the
API as large particles have high variability in dissolution time. Similarly, when the
volume fraction of the API is high (50%), high variability is encountered, where
some tablets could take 20% less time to dissolve than originally intended. In this
case, changing the dimensions of the tablet to include more excipient and thus keep
the API volume fraction lower would reduce this variability.
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Figure 6.3: Eﬀect of particle size (expressed by the correlation length) and volume
fraction on t∗90,B.
6.1.2 Effect of component solubility and diffusion coefficient
During tablet design, the choice of excipients to pair with the API determines the
component release times. In the previous section, the physical distribution of the
components was of interest but in this section the focus is on the component physical
properties. The aim of this study was to assess what eﬀect changing the diﬀusivity
and saturated concentration of one component (in this case, component A) had on
the release times of both components. This was done for 20% and 80% component A
volume fractions (Figure 6.4). The diﬀusivity factor for component A is a multiple
of the original diﬀusivity (e.g. 2DA or 12DA). Similarly, the concentration ratio is
a multiple of component A’s default saturated concentration. Relative parameters
are denoted with an asterisk. As in the previous section, component A is ten times
less soluble than component B in the default case so with a diﬀusivity factor of 1
and a concentration factor of 10, component A has the same physical properties as
component B. The correlation length of component A for all simulations was ﬁxed
at 66 µm.
Volume fraction of component A 20% 80%
Diffusivity ratio 0.5 1 2
Saturated concentration ratio 0.1 0.2 0.5 1 2 5 10
Figure 6.4: Structure of the parametric study of the eﬀect of component A’s satu-
rated concentration and diﬀusion coeﬃcient.
The t90 values for a tablet containing only component A is shown in Table 6.4
where the diﬀusivities and saturated concentrations are relative to their default val-
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ues. The values for pure component B would remain the same from the previous
study as none of its parameters were altered. For an unchanged saturated concen-
tration, changes in diﬀusivity result in a proportional change in release time and
this is most obvious for the case where csat∗A is 1. This follows from Equation 4.4 and
the fact that this study is dealing with diﬀusion controlled dissolution. Changing
the saturated concentration has an exponential eﬀect on the release times. This can
be more easily visualised by plotting this data using logarithmic scales on the axes
(Figure 6.5). Further analysis reveals that the relative integral dissolution time can
be ﬁtted as a function of relative saturated concentration through the following:
t∗90,i =
1
f1D
∗
i c
sat∗
i
+ f2D
∗
i (6.1)
where t∗90,i, D
∗
i and c
sat∗
i are the relative values of the integral release time, dif-
fusivity and saturated concentration respectively for component i and f1, f2 are
adjustable parameters. The example function in Figure 6.5 has values of f1 = 1.017
and f2 = 0.018.
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Figure 6.5: Relative release times (t∗90,A) for tablet containing only component A
against changing diﬀusivity and saturated concentration. The ﬁtted
function for 1D0 is given by Equation 6.1.
For the tablets containing 20% and 80% v/v component A, results from section
6.1.1 indicate that component B will be released quickly from the tablet containing
20% A and slowly from the one with 80% A since these compositions are either side
of the percolation threshold. These cases for component B are plotted in Figures
6.6 and 6.7. In these ﬁgures, the relative release time is taken to be with respect
to the t90 value of pure component B. At 20% v/v A, the increasing saturated
concentration and diﬀusivity of A cause a slight decrease in t∗90,B. The ideal release
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Table 6.4: Relative release times (t∗90,A) for pure component A over the parametric
space.
csat∗A
D∗A
0.5 1 2
0.1 19.70 9.85 4.93
0.2 9.87 4.93 2.47
0.5 3.97 1.98 0.99
1 2.00 1.00 0.50
2 1.02 0.51 0.25
5 0.43 0.21 0.11
10 0.24 0.12 0.06
time for component B would be approximately 80% of its pure release time (given
an 80% volume fraction) and at higher csat∗A , this is observed in all cases. When c
sat∗
A
= 10, both components have the same physical properties and have little inﬂuence
on each other. That is why the value of D∗A does not play a signiﬁcant role as c
sat∗
A
approached 10.
In the case of 80% A, component B is below its percolation threshold and therefore
is limited by the dissolution rate of A. The changes in D∗A and c
sat∗
A aﬀect t
∗
90,B in the
same way as they aﬀect component A, with the characteristic straight lines except
at higher csat∗A (5 and 10) where the properties of component A become similar to
those of B. When csat∗A is above 5, the t
∗
90,B values of component B are approximately
0.7, 0.5 and 0.4 for the relative diﬀusivities 0.5, 1 and 2 respectively.
It is important to note that when component A has the same physical properties
as that of B, the whole tablet does not behave as a single component tablet due
to the independent saturated concentrations of both components. Both component
integral release times are therefore also independent. For these cases with respect
to component A, the presence of component B does little to aﬀect t∗90,A values,
with only slight deviations from ideality at high relative diﬀusivities and saturated
concentrations.
Again, the terms API and excipient have not been assigned to either component
A or B but this study has shown that above the percolation threshold with respect
to component B, changes in the physical properties of A only aﬀect the release time
of B by 10% whereas for 80% component A, changes in its physical properties have a
marked eﬀect on the release times of B. If the volume fraction of component B is kept
well below the percolation threshold and the saturated concentration of component
A remains an order of magnitude less than that of B then the predicted eﬀect of
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Figure 6.6: Relative release times (t∗90,B) for tablet containing 20% component A.
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Figure 6.7: Relative release times (t∗90,B) for tablet containing 80% component A.
diﬀusivity on component B’s release time holds true and equations such as Equation
6.1 could be used to predict release times with reasonable accuracy.
In this case, Equation 6.1 is set equal to t∗90,B rather than t
∗
90,A and f1 is used
to scale the relative diﬀusivity of A to its eﬀect on B. Regression analysis from the
80% component A case produced f1 = 0.296 and f2 = 0.143. Table 6.5 shows the
percentage diﬀerence of t∗90,B values from Equation 6.1 with respect to the simulation
values for 80% component A. Positive values indicate the equation producing t∗90,B
below the simulation value and negative values indicating the opposite.
This type of analysis can speed up the design of formulations as changing the ex-
cipient would have a predictable eﬀect on the release time of an API without having
to resort to experiment or simulation over the entire parametric space. The speed
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Table 6.5: Relative release time (t∗90,B) percentage diﬀerences between simulated and
predicted values for 80% component A.
csat∗A
D∗A
0.5 1 2
0.1 +0.22 +0.09 -0.79
0.2 -0.02 -0.26 -1.72
0.5 -0.68 -0.70 -2.41
1 -1.26 +0.09 -2.63
2 -1.02 +2.06 -8.36
5 -1.92 -0.17 -13.4
10 -5.69 +4.94 -3.32
increase would be particularly useful for optimsation, as such a simple function takes
orders of magnitude less time to compute compared to a simulation. In this spe-
ciﬁc case, diﬀerences between the function and simulation within 5% are obtainable
though they are likely to increase as non-ideal behaviour occurs. Thus although in
these examples it is possible to ﬁt some simulation data to a function and use that
to obtain t90 values from elsewhere in the parametric space, more complex ﬁtting
methods would be needed for highly non-linear systems. However, more knowledge
about the parametric space would be needed thus rendering the ﬁtting functions
somewhat redundant as direct optimisation using full simulations would be used
instead.
6.1.3 Percolation threshold
As seen in sections 6.1.1 and 6.1.2, percolation is one of the main factors that aﬀects
component dissolution. In this study, dissolution did not occur as the main focus
was on the number of contiguous regions for diﬀerent particle size distributions and
volume fractions. From this it would be possible to see at what point component A
or B becomes continuous, and if particle size has an eﬀect on the volume fraction at
which this happens. Three diﬀerent particle sizes (66, 133 and 200 µm) were used
and for each of those, the volume fraction of component A was increased from 0
to 100% in steps of 5% and for each of these, 40 diﬀerent random seeds were used
(Figure 6.8).
This resulted in 2282 simulations, where it was not necessary to do diﬀerent
random seeds or particle sizes for 0% and 100% A and as dissolution was also not
modelled, the results can be generated quickly. The ﬁrst quantity of interest was
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Volume fraction of component A 0% 5%
Random seed 1234
Correlation length [µm] 66 133 200
10%... ...100%
1235 1235... ...1274
Figure 6.8: Structure of the parametric study of the eﬀect of particle size distribution
on the percolation threshold.
the number of discrete connected particle networks for both A and B (for example,
for small particle sizes and low volume fractions of A, it would be expected that
B would have 1 contiguous region, and A would have many). Using a recursive
algorithm, it was possible to search and label the number of discrete regions within
the tablet for each component, however it was discovered that even for high volume
fractions of one component, the number of regions could often be greater than 1,
since there would have been a very small isolated region of that component. By
plotting the volume fraction of the largest contiguous region with respect to the
total volume of that component over the range of volume fractions, it is possible to
see the point at which the largest region becomes a vast majority of that component.
The large number of random seeds were used to obtain a statistically relevant mean
and standard deviation for the number of discrete regions and the volume fraction
of the largest region.
Figure 6.9 shows the number of discrete regions and it is immediately apparent
that component A mirrors component B as φB = 1 − φA and that for the 66 µm
particles (which are around 1.6% the diameter of the tablet), a maximum is reached
around 20% v/v. For lower volume fractions, the number of regions decreases as
though they are discrete, there are just fewer in number and for greater volume
fractions, the individual particles have a greater probability of being in contact with
each other. For the larger particles, the number of discrete regions is much lower
and the variability is smaller. A minimum total number of regions (A+B) exists
where φA ≈ φB as the total probability of both components having large but still
separate regions is highest.
From Figure 6.10 it can be seen that in general, as φA increases, the volume
fraction of the largest discrete region with respect to its component increases, with
a larger change around 50% to near unity, indicating that at high φA, component A
has become a continuous phase. As the particle size increases, the relative volume
fraction of the largest discrete region also increases, with a smoother change between
40% and 60%. The variability in relative volume fraction is lowest for the 66 µm
particles but these particles are more likely to form a continuous network compared
to the large particles, at higher volume fraction. In the limit of the smallest particles
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Figure 6.9: Graph showing number of discrete regions of components A and B as a
function of φA for all three particle sizes.
(i.e. one voxel), the relative volume fraction of the largest connected region could
be ﬁtted to a cumulative normal distribution function (Figure 6.11).
If the percolation threshold is deﬁned as the point where the volume fraction of
the largest particle relative to the total volume of that component is 99%, then for
the smallest particles the threshold is crossed at approximately 70% v/v A. For the
largest particles, the threshold is crossed slightly later, at 80% v/v B. At 60% v/v
A for the smallest particles, the relative volume fraction of the largest particle is
already 92% and at 65%, it is 97%. If particle size were to decrease further, the
percolation threshold (i.e. relative volume fraction of the largest particle is greater
than 99%) would approach the theoretical value of φ = 0.66 (Baker et al., 2002).
For controlled release, it is better to have smaller particles as the likelihood of
large releases from joined networks is reduced. However with swelling tablets these
contiguous regions would be broken up as the gel layer expanded, meaning a much
higher drug loading could be used in swelling tablets than for non-swelling. Miranda
et al. (2006) found that for a swelling HPMC tablet, as long as the excipient content
was above approximately 30% v/v, the release would be controlled by the excipient,
whereas below this threshold, erosion would be the prominent release mechanism.
This is far below the value obtained in this study (where the volume fraction of
excipient would need to be above 60%) but the swelling tablets were dissolved from
all sides (axial and radial directions) compared to just the radial direction in these
simulations. In 3D, the percolation threshold for aligned cubes is approximately
30% v/v (Baker et al., 2002) due to the increased degrees of freedom, which would
give agreement with the experimental data from Miranda et al. (2006).
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Figure 6.10: Graph showing the volume fraction of the largest discrete region with
respect to component A or B as a function of φA for all three particle
sizes.
6.2 Comparison with experimental data
6.2.1 Initial set-up
The aim of these experiments was to obtain pure component parameters for the
model and then use the model to predict the release curve of a tablet with 40% w/w
of the active pharmaceutical ingredient (API). As discussed in Chapter 3 the exper-
imental set-up does not allow dissolution from the top and bottom surfaces of the
tablet, since these are covered by the ﬂow cell and ATR crystal. As such, the tablet
would dissolve only in the radial direction. The experimental set-up is therefore con-
sistent with the 2D model where dissolution also happens only in the radial direction
and not from the top or bottom facets of the tablet. Some parameters were obtained
from literature, these being the diﬀusivities of nicotinamide (8× 10−10m2s−1) and
PEG 4000 (1.7× 10−10m2s−1) (Saravacos and Maroulis, 2001; Mota et al., 1994).
The viscosity of the PEG boundary layer was considered to be a function of PEG
concentration (Kirincic and Klofutar, 1999) and the viscosity value used for the
nicotinamide boundary layer was assumed to be the same as water, approximately
1 × 10−3 Pa s. For all simulations relating to experiments, the diﬀusivity of nicoti-
namide was set not only as a function of volume fraction (Eq. 4.4) but also as a
function of PEG concentration as diﬀusivity values can vary signiﬁcantly depending
on the local concentration of other species (Saravacos and Maroulis, 2001), especially
if these are higher molecular weight substances. The discretisation of the tablet and
surrounding boundary layers was set to 20 µm. The densities of nicotinamide and
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Figure 6.11: Volume fraction of the largest discrete region with respect to component
A as a function of φA for particle size equal to one voxel with a ﬁtted
cumulative normal distribution function.
PEG were found experimentally to be approximately 1400 and 1200 kgm−3 respec-
tively. The maximum boundary layer thickness found using the Hilpert correlation
is 200 µm assuming the boundary layer contains a saturated concentration of PEG.
During simulations, the average concentration of PEG within the boundary layer
was used, giving a boundary layer thickness of 100 µm for PEG and 160 µm for
nicotinamide.
6.2.2 Determination of saturated concentration
The saturated concentrations of both components were unknown and needed to be
determined experimentally. As all other variables were known, the model along
with results from experiments could be used to ﬁnd these values. Release curves
produced by the simulation were compared to those from the experiments using
the mean squared error (MSE) and thus minimisation of the MSE would result in
the best value of saturated concentration for that particular component. Firstly,
a pure (100% w/w) nicotinamide tablet was dissolved, a release curve obtained
and optimisation was performed by the model. The saturated concentration of
nicotinamide was found to be 603 kgm−3.
As PEG is not detected by UV/Vis, it was necessary to use some nicotinamide
in the tablet to get a release curve for PEG indirectly. It was assumed that for low
fractions of nicotinamide, the release would be dominated by the PEG, and thus
the release of PEG could be assumed to follow that of nicotinamide. The value
for the saturated concentration of nicotinamide was set as 603 kgm−3 (as found
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Figure 6.12: Absorbance images for PEG, nicotinamide and water with nicoti-
namide. The insert at the top shows the position of the ﬁeld of view
relative to the entire tablet.
previously) and nicotinamide was 10% w/w of the tablet. For this 10% case, the
simulations was run 3 times to minimise the eﬀects of particle distribution. The
saturated concentration of PEG was 470 kgm−3.
6.2.3 Prediction of nicotinamide release
With all physical properties for the drug and excipient known, the computer model
could simulate a tablet dissolving containing any fraction of drug. In this section,
a 40% w/w nicotinamide tablet was simulated and compared with the same tablet
dissolved and imaged experimentally. The value of 40% was chosen because based on
previous parametric studies, it lies in the most “diﬃcult” region, i.e. the region with
a high parametric sensitivity of dissolution with respect to composition. Results
from FTIR spectroscopic imaging for the 40% w/w nicotinamide tablet are shown
in Figure 6.12. Despite a small crack on the left side of the images, water does not
penetrate into the tablet, validating the assumption used in the simulation of no
water penetration into the solid phase. The boundary layer thickness for PEG can
be seen in Figure 6.13 and is approximately 100-200 µm, which is similar to that
obtained using the Hilpert correlation.
Simulations were done in triplicate to minimise the possible eﬀect of tablet het-
erogeneity, with a resulting MSE of 8.65 × 10−4 compared to the experiment. All
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Figure 6.13: Absorbance proﬁles of PEG over time derived from absorbance images
(Figure 6.12). Values adjacent to the curves correspond to the number
of minutes elapsed.
release curves from simulations and experiments are shown in Figure 6.14, with the
UV/Vis and simulation release curves are in excellent agreement. Dissolution front
positions from the FTIR images and simulations were also compared as a function of
tablet radius. The front position for the FTIR images was determined from the PEG
images and is shown in Figure 6.13. A slight time oﬀset is seen in the radius from
the experiment possibly due to starting the measurement process before constant
ﬂow had been established in the ﬂow cell. Oﬀsetting the experimental data shows
the gradient is identical to the simulation, though with the small ﬁeld of view in the
experiments, it is not possible to determine the position of the solid phase boundary
for the whole duration of the dissolution experiment. The stepped appearance of
the simulation curve is due to the discretisation of the tablet.
6.3 Conclusions
From the computational investigation into the eﬀects of tablet composition and
particle size on component release times, the following observations have been made.
For the less soluble component (component A), changes in its volume fraction and
particle size caused little deviation of its release time from the ideal homogeneous
case. For highly soluble component B, the presence of A had a marked eﬀect on its
release times. Increases in the fraction of A caused an increased release time of B as
component A would trap and limit the rate of release of B. Similarly for low fractions
of component B, increasing particle size had an increasing eﬀect on the release time
variability of B as the particle distribution and size became important factors. For
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Figure 6.14: Release curves obtained from simulations and experimental data. An
iterative process was used to ﬁnd the saturated concentration values for
nicotinamide from the 100% case and PEG from the 10% case. These
regressed values and known parameters from literature were used to
simulate a 40% tablet dissolving, with experimental data shown for
comparison.
the largest particles at 20% v/v component B, the release time variability of B was
almost 30% its average value. For the cases where the fraction of component B was
high (80% v/v), the eﬀect of particle size was diminished due to percolation eﬀects.
A minimum value release time was also observed at this volume fraction, where the
presence of component A enhanced the release rate of B due to the increased surface
area. This study demonstrated that for tablets containing a highly soluble drug,
the release time can vary substantially depending on the particle sizes and particle
distribution of the drug. Therefore mixing and particle size would be important
factors to control during tablet manufacturing in order to ensure consistent drug
release times across diﬀerent tablets.
For the study into component solubility and diﬀusivity, a correlation was obtained
relating relative diﬀusivity and relative saturated concentration of component A to
its relative release time (Eq. 6.1). For 80% v/v component B, the changes in
parameters for A had little eﬀect on component B’s release rate since component
B was above the percolation threshold. However, for 20% v/v, the release rate
of component B was eﬀectively limited to the rate at which component A would
dissolve so changes in parameters for A had the same eﬀect on B as they did for
A and Equation 6.1 would thus be valid with respect to B. As the properties of
component A approached those of B, the relative release times predicted by the
equation deviate slightly from the simulation results. This function could be useful
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Figure 6.15: Change in tablet radius over time for FTIR experimental data and
simulations.
in predicting the change in release time of an API where a new excipient is used
if the relative diﬀusivities and saturated concentrations of the excipient are known.
In practice, this would often be the case since excipients are normally chosen from
a relatively small set of compounds that tend to be used repeatedly even in new
formulations with new APIs.
The percolation threshold study conﬁrmed what was observed in the previous
parametric studies where volume fractions approaching a high value would begin to
form contiguous regions and above approximately 0.6, would form a single contiguous
region. Tablets containing large particles showed fewer contiguous regions compared
to the small particles, but the component speciﬁc volume fraction of the largest
contiguous region would be higher for large particles compared to smaller particles
for the same overall volume fraction. This conﬁrmed that particle size as well as
overall volume fraction is crucial in maintaining low variability in release.
The experimental work shows that it is possible to use a combination of FTIR
spectroscopic imaging and UV-Visible spectroscopy to estimate physical parame-
ters for the computer model, and then compare the simulation and experimental
data. Success was shown in obtaining and regressing parameters from literature
and initial experiments, which were then used to predict a 40% w/w nicotinamide
tablet dissolution with a low mean squared error (8.65× 10−4). The boundary layer
thickness obtained from FTIR images and estimated using the Hilpert correlation
also showed reasonable agreement, validating the assumptions about the ﬂow regime
within the dissolution cell. The FTIR images also validated the assumptions about
no water penetration into the tablet matrix and fast API dissolution compared to
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the polymer. The agreement for the predicted case (40%) and experiment is good,
but the ﬁtting of the simulation to the 10% case was more diﬃcult. The reason for
this could be due to changes in tablet geometry during dissolution caused by the
slight gelling of the PEG. Chan (2004) found that for PEG 4000, the Peppas model
indicated slight non-Fickian dissolution characteristics.
This work has demonstrated that by using a combination of FTIR spectroscopic
imaging, UV-Visible spectroscopy and knowledge obtained from parametric studies,
it is possible to derive parameters for the computer model and have the computer
model produce a release curve that agrees quantitatively with that from experi-
ments. The model can then be applied to optimisation of formulations to produce
tablets with the desired controlled release properties by changing the formulation
parameters. A potential optimisation parameter is the excipient solubility and dif-
fusivity, and changing these via the polymer chain length enables the API release
rate to be tuned (Miller-Chou and Koenig, 2003).
7 Swelling Tablet Simulation and
Experimental Results
This chapter contains the parametric studies and experimental optimisation results
for the swelling model, which has been published (Kimber et al., 2012).
7.1 Parametric studies
The release kinetics of drugs from swellable polymers are directly aﬀected by the
physical properties of the polymer and the advantage of modelling is that these prop-
erties can be investigated independently of each other. The key parameters are the
concentration dependent diﬀusion coeﬃcient (which was present in the non-swelling
code but not studied), the disentanglement threshold and the dissolution rate co-
eﬃcient. The equilibrium water concentration was not investigated as it simply
determines the maximum size the polymer will swell before dissolution occurs. The
results of the parametric studies could then be used in determining which parame-
ters to optimise when comparing the experimental results of swelling and dissolution
to those obtained by the model. As in the previous chapter, it is common to specify
a time when 90% of the API has been released, so called t90. In this section for
non-dissolving formulations, t90 is the time taken for the mass fraction of water to
reach 90% of the critical water fraction for the entire tablet. For dissolving formu-
lations, the end-point of the simulation is when 90% of the polymer has dissolved.
The evolution of the tablet radius over time is also of interest as this information
can also be used to target parametric optimisation when comparing simulations with
experiments.
Table 7.1 shows the parameter values used in these parametric studies unless
otherwise indicated. Parameters Dw, ρp, φd are based on a typical swelling excipient
used in pharmaceutical tablets, Hydroxypropyl methylcellulose (HPMC) (Kiil and
Dam-Johansen, 2003). The magnitude of kdiss was estimated from Borgquist and
Maggi (Borgquist et al., 2006; Maggi et al., 2000).
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Table 7.1: Base-case parameter values used in the simulations.
Parameter Unit Value
Initial tablet radius rt(t = 0) m 1.5× 10−3
Tablet height dz m 1.0× 10−3
Polymer density ρp kgm−3 1300
Water density ρw kgm−3 1000
Water diffusivity minimum Dwmin m
2 s−1 2× 10−11
Water diffusivity maximum Dwmin m
2 s−1 2× 10−10
Polymer dissolution const. kdiss ms
−1 1× 10−8
Critical water mass fraction φ∗ - 0.9
Disentanglement threshold φd - 0.8
Diffusion exponential β - 0.0
DEM particle radius ri m 5× 10−5
7.1.1 Concentration dependence of the water diffusion
coefficient
The diﬀusion of water through the polymer directly aﬀects the rate of swelling
and by extension, drug release. The linearity of the relationship between water
concentration and its diﬀusion coeﬃcient was adjusted using the parameter β which,
from Equation 4.26 and Figure 7.1, shows increasing β causes the concentration
proﬁles to sharpen. The diﬀerence between Dwmax and D
w
min would also have an
eﬀect on swelling so these parameters were investigated together and the dissolution
constant kdiss was ﬁxed. The minimum diﬀusion coeﬃcient Dwmin was also kept
constant and three values of Dwmax were used (2.5, 5 and 10 ×Dwmin). The eﬀect of
changing the diﬀusion coeﬃcient ratio and β is shown in Figure 7.2.
In these cases, there are two competing processes that contribute to the tablet
radius evolution, one is the rate of diﬀusion of water into the tablet, which controls
swelling and the other is the rate of dissolution. It is clear from Equation 4.27
that the change in radius over time is constant where there is only dissolution and
in the case where diﬀusion ratio is very large (Dwmax/D
w
min = 10), the tablet swells
to a higher maximum before its radius decreases at a constant rate than for lower
diﬀusion ratios. The rate of swelling is much faster when β < 1 as at low water
concentrations within the tablet, the diﬀusion coeﬃcient is already approaching
Dwmax, whereas when β > 1 the diﬀusion coeﬃcient approaches D
w
max at high water
concentrations. The overall dissolution time does not change drastically compared
to the overall tablet expansion, and a large degree of overlap can be seen between
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Figure 7.1: Concentration proﬁles from DEM simulation for diﬀerent values of β
after 8 hours of swelling where Dmax = 10Dmin.
the curves, suggesting that whilst the internal concentration proﬁles would diﬀer,
the overall tablet radius can be kept more or less the same for diﬀerent diﬀusion
ratios and values of β. There are also two limiting cases, one where β = 0, Dw =
Dwmax ∀cw and the other when β = ∞, Dw = Dwmin ∀cw. These results show that
Equation 4.26 can capture the concentration dependence in diﬀusion coeﬃcient that
occurs as the polymer swells and components diﬀuse through it. When optimising
against experimental data, it is important to remember that for certain parameter
combinations, the external tablet radius over time can appear identical but the
internal concentration proﬁles may still diﬀer. When applying this equation to drug
release, diﬀerent components would have diﬀerent values of β, Dmin and Dmax due
to the diﬀerent sizes of molecules passing through the polymer matrix (Barba et al.,
2009a) and these values could be obtained by studying the various concentration
proﬁles within the tablet using optimisation. The nature of the code also allows
the diﬀusion coeﬃcients to be deﬁned by any arbitrary functions depending on the
particular components present and thus could model other polymer behaviour such
as pH dependent diﬀusivity (Liu et al., 2009).
7.1.2 Disentanglement threshold
The disentanglement threshold is a function of polymer chain length and aﬀects
the dissolution of the polymer (Narasimhan, 2001). In the extreme cases, a high
disentanglement threshold would enable the tablet to take up a lot of water before
dissolving and on the contrary, a low or zero disentanglement threshold would cause
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Figure 7.2: Tablet radius over time for diﬀerent values of β and Dwmax. The ﬁrst
number in each label corresponds the the ratio Dwmax : Dmin and the
second corresponds to the value of β.
the polymer to dissolve straight away (the tablet would essentially be non-swelling
in that case). From Figure 7.3, as the disentanglement threshold decreases, the
tablet approaches the behaviour of a non-swelling tablet. It is also seen that for
low φd, the eﬀect of tablet discretisation becomes apparent as the DEM particles
do not swell much before dissolving and the jagged appearance is due to particles
being removed as they fall below the cut-oﬀ radius (which prevents the DEM code
from becoming unstable or taking an excessive time to ﬁnd the particle equilibrium
positions). Increasing the number of particles and decreasing the cut-oﬀ threshold
would reduce this eﬀect. In a multicomponent system, diﬀerent components could
swell by diﬀering amounts, so that drug particles could simply dissolve within the
gel, whilst the gel layer would expand to a greater extent. For a large φd, there is
a plateau i.e. a relatively long period during which the external tablet radius does
not change although internal diﬀusion processes continue. As φd approaches φ∗,
the driving force for water penetration decreases as seen in Figure 4.12 and so the
polymer can maintain its expanded state for longer.
7.1.3 Dissolution rate constant
The apparent dissolution rate constant characterises the mass transfer of polymer
from the tablet to the bulk solution. The thickness of the boundary layer surrounding
the tablet is aﬀected by the ﬂuid velocity around the tablet and suitable correlations
such as the Hilpert correlation (Hilpert, 1933) could in principle be used to estimate
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Figure 7.3: Tablet radius over time for diﬀerent values of φd. β = 1, Dmin = Dmax =
2× 10−11, kdiss = 1× 10−8.
the mass transfer coeﬃcient. In stagnant conditions, the polymer release is limited
by diﬀusion and at high ﬂow rates, the rate of polymer dissolution will be limited by
the inherent reptation time of the polymer. At higher ﬂow-rates, the polymer would
be eroded and the shape of the gel layer distorted and although this ﬂow regime is
unlikely in the context of pharmaceutical tablets, the DEM model could take into
account the ﬂuid forces and have the particles move accordingly. Figure 7.4 shows
the eﬀect on tablet radius as a result of increasing dissolution rate constant and as
seen in the previous section, the discretisation becomes a factor in the smoothness
of release the curves. The eﬀect of φd can also be seen, as when the kdiss is very
high, there is a minimum swelling radius before the tablet begins to shrink and for
lower values, the tablet can expand to a greater extent (up to the limit imposed by
φ∗).
7.2 Comparison with experimental data
To compare the model with experiments, tablets consisting of HPMC K100 LV were
dissolved in a ﬂow cell and imaged, whilst a similar tablet dissolving was simulated.
Compared to the non-swelling case, it was more diﬃcult to obtain parameters for
the model such as the value of β or the critical water mass fraction (φ∗) as these
parameters are speciﬁc to the model and the grade of HPMC, thus they cannot be
obtained easily from literature although as stated in section 7.1, the parameters can
be based on some literature values (Table 7.2).
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Figure 7.4: Tablet radius over time for diﬀerent values of kdiss relative to 1 × 10−8.
β = 1, Dmin = Dmax = 2× 10−11, φd = 0.8.
During dissolution, the FTIR images in Figure 7.5 show the tablet as a ring, with
little polymer in the centre. This is due to poor contact on the ATR crystal from
the solid phase and good contact from the gel phase but this does not aﬀect the
rate of water ingress as water leakage into the interface between the tablet and ATR
crystal is negligible (van der Weerd and Kazarian, 2004b).
Table 7.2: Parameters used to match DEM simulations to FTIR image data.
Parameter Unit Value
Water diffusivity minimum Dwmin m
2 s−1 2× 10−11
Water diffusivity maximum Dwmax m
2 s−1 2× 10−9
Polymer dissolution const. kdiss ms
−1 2× 10−7
Critical water mass fraction φ∗ - 0.946
Disentanglement threshold φd - 0.7
Diffusion exponential β - 4.0
The parameters φ∗ and φd were optimised in order to match the DEM tablet
radius to the radius calculated from the FTIR images and all other parameters
were kept the same as from Table 7.1. Concentration proﬁles were obtained by
looking at a strip of vertical pixels from the centre of the tablet to the edge of the
image and plotting the polymer absorbance, and these were used to ﬁnd a good β
value. Due to noise in the concentration proﬁles, the tablet radius was deﬁned as
a position where the normalised polymer absorbance was 10%. Figure 7.6 shows
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Figure 7.5: FTIR images of an HPMC tablet swelling and dissolving. The magenta
line at t = 0 in the FTIR images shows where the concentration proﬁles
are taken.
the tablet radius obtained by simulation matches well with the experimental one
when the optimised values are used. However, the concentration proﬁle at 100
minutes (Figure 7.7) whilst matching in shape appears to be too far into the tablet
compared to the FTIR imaging data. The possible reasons for this are that the
tablet porosity is not taken into account (where imbibing water would not cause
swelling), the polymer changes density upon chain relaxation (which would result in
a higher degree of swelling for a set amount of water ingress) and the concentration
dependent diﬀusion coeﬃcient function does not capture the correct polymer/water
behaviour (which would change the rate of water diﬀusion and the shape of the
concentration proﬁle). The diﬀerence may also be explained by the FTIR data,
since it appears that the normalised concentration of polymer is still unity, even
though water ingress and polymer expansion has occurred and that the cross-over
point between polymer and water for both DEM and FTIR imaging is in almost
the same radial position. Nevertheless, models so far presented in literature have
not considered the polymer concentration proﬁles (they focus on drug release and
swelling fronts as they are easier to measure). As ATR-FTIR imaging can obtain
this additional information (intra-tablet concentration proﬁles of each component),
further investigations would be needed to improve the match between FTIR and
DEM concentration proﬁles.
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7.3 Conclusions
Parametric studies that were conducted focussed on the main factors that deter-
mine polymer dissolution, these being the concentration dependent water diﬀusion
coeﬃcient, the dissolution rate constant of the polymer and the disentanglement
threshold. It was shown that both the diﬀusion coeﬃcient ratio and β inﬂuenced
the overall rate of swelling and interestingly, diﬀerent combinations could produce
similar results when looking at tablet radius only. However, as β has the eﬀect
of changing the internal concentration proﬁles it is important to keep this in mind
when applying the model for drug release or comparing the simulation concentra-
tion proﬁles with experimental data. The other parameters φd and kdiss also had
important eﬀects, causing changes in the swelling and dissolution behaviour. From
the point of view of tablet swelling, all of these parameters depend on each other
hence when applying the model for optimisation against experimental data, it is
important to observe the inner concentration proﬁles as well as the tablet radius.
The ATR-FTIR spectroscopic imaging approach was used to obtain the internal
concentration proﬁles and although the tablet swelling radius matched reasonably
well, there were slight diﬀerences in the internal concentration proﬁles which would
require further investigation to improve the model.
8 Conclusions and Future Work
8.1 Conclusions
In this thesis, a computational model was developed to simulate tablet dissolution
in-silico. Crucially, the models were developed in conjunction with supporting data
from the chemically speciﬁc and spatially resolved FTIR imaging approach. This
allowed the derivation of physical properties required for the model. FTIR imaging
also provided a platform for validation of the model against experimentally obtained
data.
8.1.1 Non-swelling model
8.1.1.1 Numerical parametric studies
The non-swelling model was based on a Cartesian coordinate system where mass
transfer was solved between each cubic volume element. The model was successfully
validated against an analytical solution, enabling further numerical studies to be
conducted. The non-swelling simulations used two component tablets, where com-
ponent A was 10 times less soluble than component B but otherwise identical. In
the ﬁrst parametric study, the volume fraction of each component, particle size and
particle size distribution were changed to see what eﬀects they would have on each
component’s release. As component A was less soluble, changes in its volume frac-
tion and particle size did not have much eﬀect on the release rate of component B.
However, component A had a large inﬂuence on component B’s release as component
B would be rate controlled by component A. For large particle sizes, the variability
of component B’s release was high due to the consequences of random placement,
where some large particles were on the edge of the tablet and thus their dissolu-
tion was not slowed by component A. When the volume fraction of component B
was high, it was above the percolation threshold, and formed a continuous network
(where above this point, discrete domains of component A would be surrounded by
component B). This study indicated that for highly soluble drugs, the rate-limiting
component (in this case, component A) must be above the percolation threshold so
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as to fully surround component B. It was also seen that the particle size of B should
be small to avoid a large variability in its release time. This demonstrated the im-
portance of controlling particle size and the selection of an appropriate excipient, as
well as the maximum loading of API the tablet should have.
The second parametric study focussed on the relative saturated concentration and
relative diﬀusion coeﬃcient of component A (with respect to the unmodiﬁed values of
A). For a tablet containing only A (so as to see what eﬀect changing these parameters
has on their own), it was found that doubling the diﬀusion coeﬃcient halved the
relative release time, and similarly, changing the relative saturated concentration
changed the relative release time by the same proportion. This was expected as the
concentration gradient was eﬀectively being scaled by these factors. It was found
that when component A was a minority component (20% v/v), the release time of B
was not aﬀected much, whereas when component A was in the majority (80% v/v),
the release rate of B was substantially aﬀected. It was shown that a simple scaling
formula could be used to predict the relative change of component B’s release time.
The ﬁnal parametric study was a more in-depth study of the percolation threshold
where no dissolution was conducted, rather the variables of interest were the volume
fraction of the largest discrete region relative to the total volume fraction of that
component within the tablet. This would give a measure of the size of the largest
contiguous region, as increasing the volume fraction of that component would in-
crease the probability its particles would be in contact. At a certain volume fraction
(the percolation threshold), the probability of particles being in contact with each
other to form a continuous network would be very high. It was found that the larger
particles would be more likely to form a continuous network compared to the smaller
ones, again highlighting the importance of particle size control. When particles were
the minimum size i.e. the discretisation grid size, the relative volume fraction of the
largest contiguous region approached a cumulative distribution function.
8.1.1.2 Experimental
In order to test the non-swelling model, tablets made of a relatively non-swelling
excipient (polyethylene glycol 4000) and a highly soluble drug (nicotinamide) were
dissolved using a ﬂow cell and imaged using the ATR-FTIR spectroscopic imaging
approach. The ﬁrst part of this study was to determine the saturated concentrations
of both PEG and nicotinamide as these were unknowns (the other physical property
values such as density, diﬀusivity etc were obtained from literature). In addition,
a boundary layer was set up in the simulation, whose thickness was derived from
the Hilpert correlation for ﬂow around cylinders and the ﬂow conditions in the
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dissolution cell. Optimisation was used to minimise the diﬀerence between the
experimental and simulated release curves of nicotinamide by changing the value of
the simulation saturated concentrations.
The predictive model was tested against a 40% tablet i.e. a tablet containing 40%
nicotinamide was dissolved both in-silico and experimentally and the release curves
compared. The mean squared error between the two release curves was 8.65× 10−4,
showing that the model can be used to model tablet dissolution accurately based
only on pure component properties.
8.1.2 Swelling model
8.1.2.1 Numerical parametric studies
The swelling model discretised the tablet into DEM particles which had a radius as a
function of the mass within them. A novel algorithm was used to calculate the mass
transfer area between DEM particles, which was shown to be fast and suﬃciently
accurate for modelling swelling polymer tablet dissolution.
The key parameters which control the behaviour of the swelling tablet were the
disentanglement threshold φd, the dissolution rate constant kdiss the minimum and
maximum water diﬀusion coeﬃcient and the linearity of the concentration dependent
diﬀusion coeﬃcient, aﬀected by the parameter β.
It was found that the greater the diﬀerence between the minimum and maximum
diﬀusion coeﬃcient of water, the greater the amount by which the tablet would swell
and reach the disentanglement threshold, hence the tablets with higher maximum
diﬀusion coeﬃcients would dissolve slightly faster. The linearity parameter β was
shown to aﬀect the maximum swelling but did not signiﬁcantly aﬀect the total
dissolution time of the tablet. The internal concentration proﬁles of water and
polymer were aﬀected strongly by β, which would aﬀect the release rate of drug if
it were present.
By changing the disentanglement threshold φd, the maximum expansion of the
tablet would increase from no swelling when φd = 0 to φd = 0.8. If the disentangle-
ment threshold was set higher than the critical water concentration, the tablet would
never dissolve and the swelling polymer would behave like a cross-linked hydrogel.
The dissolution rate constant aﬀected the rate at which the tablet would dissolve
once it had passed the disentanglement threshold.
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8.1.2.2 Experimental
The parameters studied in Section 7.1 aﬀect the tablet swelling in 3 ways: the diﬀu-
sion coeﬃcient parameters aﬀect the rate of swelling, the disentanglement threshold
aﬀects the maximum amount the tablet can swell and the dissolution rate constant
aﬀects the rate of in which the tablet dissolves, reducing in radius. The parame-
ters are not completely independent of each other, i.e. similar swelling behaviour
could be obtained with slightly diﬀerent parameter values. An HPMC tablet was
dissolved and imaged, where the outer radius was compared to the model. Through
optimisation it was possible to match both the outer tablet radius and the internal
concentration proﬁles reasonably well.
8.2 Overall conclusions
Both models have demonstrated the ability to simulate a wide variety of tablet be-
haviour, which is useful when optimising formulations. The importance of particle
size and the percolation threshold were shown and the use of ATR-FTIR imaging
gave insight into the dissolution process. For the ﬁrst time a numerical model that
explicitly captures the heterogeneous internal tablet microstructure was directly val-
idated against spatially and temporally resolved concentration proﬁles of individual
components of the tablet formulation.
8.3 Future work
The potential for further development of the DEMmodel is clear and the use of FTIR
spectroscopic imaging to provide valuable insight into tablets undergoing dissolution
would be an important part of validating the model. In continuing this work it would
be possible to progress towards the goal of being able to fully optimise and test
formulations using only the pure component material properties and their spatial
arrangement.
The most obvious extension to the existing model is the dissolution of drug DEM
particles from a swelling polymer tablet. The particle size and size distribution tests
from Chapter 6 could then be applied to the swelling model, with the added feature
that polymer swelling behaviour would move the drug particles around. This could
lead to a case where the fraction of drug is above the percolation threshold, but due
to fast polymer expansion, the volume fraction of drug falls below the percolation
threshold and release is controlled.
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The model also uses a gravitational force to maintain a close particle. However
this is speciﬁc to cylindrical symmetry and would not work for other geometries. As
discussed in Section 4.2.5.4, the gravity term could be replaced by a particle attrac-
tion force based on the properties of the gel layer. This opens up the possibilities
of studying gel formation, as if water penetrates into the glassy core faster than the
gel can form, the large stresses cause the tablet to fracture (Lecomte et al., 2005).
Some drugs exhibit increased solubility in the polymer gel or in the presence of
other species (for example, ibuprofen dissolves well in basic conditions (Wray et al.,
2011)). In other cases, an enteric coating would slow the ingress of water into the
tablet until the pH was above a certain level, giving targeted release. Disintegrant
particles which either expand very quickly to break up the tablet, or dissolve very
quickly to increase the porosity of the tablet are also a possibility, enabling a for-
mulation to be ﬁne-tuned through the addition or removal of disintegrants.
Extending the model to 3D would enable a wide range of tablets to be simulated
along with investigations into phenomenon like the “butterﬂy eﬀect” (Cahyadi et al.,
2011). It is known that tablets expand to a greater extent along the axis in which
they were compacted (Gao and Meury, 1996) hence the move to 3D would give a
more true representation of swelling tablet behaviour. Structured tablets such as
tablet-in-tablet (Gazzaniga et al., 2008), biphasic (Kikkinides et al., 1998) or osmotic
pumps (Langer and Peppas, 1983) could be modelled more accurately in 3D. The
3D model would need to be evaluated against analytical solutions much like the 2D
method was (Kimber et al., 2011a).
The inverse problem (i.e. specifying a time for drug to be released and optimising
parameters to achieve that) could be solved for a variety of swelling tablets which
would demonstrate the predictive capabilities of the model. The model itself could
be applied to any system where mass transfer occurs through porous media such as
the swelling of detergent granules into a gel.
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